Press CTRL + F from keyboard to search
| No | TEST CODE |
TEST NAME | Method | SPECIMEN | TEMP. | Usage |
| 1 | 5100 | ABO GROUP & RH TYPE, EDTA WHOLE BLOOD | TUBE AGGLUTINATION | EDTA WHOLE BLOOD/ SERUM | EDTA ,PLAIN . 2-8 °C 24 HR | Blood group is identified by antigens and antibodies present in the blood. Antigens are protein molecules found on the surface of red blood cells. Antibodies are found in plasma. To determine blood group, red cells are mixed with different antibody solutions to give A,B,O or AB. Disclaimer: “Please note, as the results of previous ABO and Rh group (Blood Group) for pregnant women are not available, please check with the patient records for availability of the same.” The test is performed by both forward as well as reverse grouping methods. |
| 2 | 1262 | ABS EOSINOPHIL COUNT, EDTA WHOLE BLOOD | AUTO ANALYSER | EDTA WHOLE BLOOD | EDTA . 2-8 °C 24 HR | When the absolute eosinophil count exceeds 400 cells/cumm it is termed as Eosinophilia. AEC is subject to diurnal variations. AEC level is inversely related to blood glucocorticoid levels. Increased eosinophils are seen most commonly in allergic reactions including drug sensitivity & skin diseases and parasitic infestations. The other less common causes are lymphoproliferative disorders, collagen disorders, Loeffler””””””””s syndrome, rabies and less active phase of malaria. |
| 3 | 5320 | ACID FAST BACILLI (AFB) SMEAR (MYCOBACTERIA DETECTION) |
MICROSCOPY / ZIEHL NEELSEN STAIN | ANY SPECIMEN EXCEPT BLOOD, BONE MARROW.SWAB NOT ACCEPTABLE | A/R | ACID FAST BACILLI SMEAR The direct smear microscopy is a reliable and simple technique for detection of AFB. The method consists of microscopic examination of a specimen that has been spread on a slide and stained. Mycobacterial cell walls have a high lipid content that resists staining, however once stained, the bacterial cell resists decolourisation by strong acids or alcohols. Hence these bacteria are known as “”acid – fast.””The sensitivity of microscopy for detection of acid fast bacilli is about 10,000 bacilli /ml. of the specimen. Many reports have shown that the mycobacteria may be released irregularly from the lungs. Thus, it is advisable to screen more than one specimen. Secretions build up in the airways overnight; so an early morning sputum sample is more likely to contain AFB than a sample collected later in the day. Organisms other than mycobacteria may demonstrate various degrees of acid fastness. Such organisms include Rhodococcus, Nocardia, Legionella and cysts of Cryptosporidium and Isospora species. |
| 4 | 5320S | ACID FAST BACILLI SMEAR (3 SAMPLES) | MICROSCOPY / ZIEHL NEELSEN STAIN | SPUTUM / URINE /FLUID | R | ACID FAST BACILLI SMEAR The direct smear microscopy is a reliable and simple technique for detection of AFB. The method consists of microscopic examination of a specimen that has been spread on a slide and stained. Mycobacterial cell walls have a high lipid content that resists staining, however once stained, the bacterial cell resists decolourisation by strong acids or alcohols. Hence these bacteria are known as “”acid – fast.””The sensitivity of microscopy for detection of acid fast bacilli is about 10,000 bacilli /ml. of the specimen. Many reports have shown that the mycobacteria may be released irregularly from the lungs. Thus, it is advisable to screen more than one specimen. Secretions build up in the airways overnight; so an early morning sputum sample is more likely to contain AFB than a sample collected later in the day. Organisms other than mycobacteria may demonstrate various degrees of acid fastness. Such organisms include Rhodococcus, Nocardia, Legionella and cysts of Cryptosporidium and Isospora species. |
| 5 | 5320U | ACID FAST BACILLI SMEAR (5 SAMPLES) | MICROSCOPY / ZIEHL NEELSEN STAIN | SPUTUM / URINE | R | ACID FAST BACILLI SMEAR The direct smear microscopy is a reliable and simple technique for detection of AFB. The method consists of microscopic examination of a specimen that has been spread on a slide and stained. Mycobacterial cell walls have a high lipid content that resists staining, however once stained, the bacterial cell resists decolourisation by strong acids or alcohols. Hence these bacteria are known as “”acid – fast.””The sensitivity of microscopy for detection of acid fast bacilli is about 10,000 bacilli /ml. of the specimen. Many reports have shown that the mycobacteria may be released irregularly from the lungs. Thus, it is advisable to screen more than one specimen. Secretions build up in the airways overnight; so an early morning sputum sample is more likely to contain AFB than a sample collected later in the day. Organisms other than mycobacteria may demonstrate various degrees of acid fastness. Such organisms include Rhodococcus, Nocardia, Legionella and cysts of Cryptosporidium and Isospora species. |
| 6 | 9333 | ACID PHOSPHATASE (PROSTATIC) (ONLY FOR WALKIN PATIEN) | SPECTOPHOTOMETRY | SERUM + CLINICAL HISTORY + (AGE & GENDER IS MANDATORY) | F | Prostatic Acid phosphatase (PAP) is more commonly used for diagnosis of carcinoma of prostate, metastatic; monitor therapy with antineoplastic drugs and evaluate possible histiocytosis. |
| 7 | 3895 | ACT PARTIAL THROMBO PLASTIN TIME(APTT), | COAGULOMETER | FROZEN CITRATE PPP AT -20 C | BLUE TOP. RT 2 HR ;4°C 4 HR; -20 for 2 WEEK | ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT), PLASMA The activated partial thromboplastin time (APTT) reflects the activities of most of the coagulation factors, including factor XII and other “”contact factors”” (prekallikrein [PK] and high molecular weight kininogen [HMWK]) and factors XI, IX, and VIII in the intrinsic coagulation pathway, as well as coagulation factors in the common coagulation pathway that include factors X, V, II and fibrinogen (factor I). The APTT also depends on phospholipid (a partial thromboplastin) and ionic calcium, as well as the activator of the contact factors (eg, silica) present in the reagent, but reflects neither the integrity of the extrinsic coagulantion pathway that includes factor VII and tissue factor, nor the activity of factor XIII (fibrin stabilizing factor). The APTT is variably sensitive to the presence of specific and nonspecific inhibitors of the intrinsic and common coagulation pathways, including lupus anticoagulants or antiphospholipid antibodies. It is useful for monitoring unfractionated heparin therapy, for screening for certain coagulation factor deficiencies, detection of coagulation inhibitors such as lupus anticoagulant, specific factor inhibitors, and nonspecific inhibitors. APTT “mixing” studies: Poor or partial correction of the abnormal result by normal plasma may be observed in the presence of coagulation factor inhibitors, anticoagulant drugs such as heparin or direct thrombin inhibitors. Total correction indicates coagulation factors deficiency. |
| 8 | 3102 | ADRENOCORTICOTROPIC HORMONE (ACTH) – COMPLETE | CHEMILUMINESCENCE | Plasma-EDTA ( Collect blood into iced EDTA tubes, noting the time of collection. The tubes should be immersed in an ice bath following collection. Freeze the specimen immediately after separation. Specimen collected between 6-10 am is desirable) + Clinica | F (Upto 30 days) | In a patient with hypocortisolism, an elevated adrenocorticotropic hormone (ACTH) indicates primary adrenal insufficiency, whereas a value that is not elevated is consistent with secondary adrenal insufficiency from a pituitary or hypothalamic cause. In a patient with hypercortisolism (Cushing syndrome), a suppressed value is consistent with a cortisol-producing adrenal adenoma or carcinoma, primary adrenal micronodular hyperplasia, or exogenous corticosteroid use. |
| 9 | 1221CS | AEROBIC CULTURE- ISOLATION & IDENTIFICATION (Culture + Sensitivity) | CULTURE + SENSITIVITY BY VITEK | SCRAPINGS / PUS/ TISSUE IN SALINE-STERILE CONTAINER(Swabs not accepted) | R | A culture is a test to find germs (such as bacteria or a fungus) that can cause an infection. A sensitivity test checks to see what kind of medicine, such as an antibiotic, will work best to treat the illness or infection. |
| 10 | 1221CSM | AEROBIC CULTURE- ISOLATION & IDENTIFICATION (Culture + Sensitivity) Manual | CULTURE + SENSITIVITY BY MANNUAL METHOD | SCRAPINGS / PUS/ TISSUE IN SALINE-STERILE CONTAINER(Swabs not accepted) | R | #N/A |
| 11 | 1195AP | AEROBIC CULTURE, BODY FLUID BACTEC | BACTEC FLUORESCENT METHOD | BODY FLUID- STERILE CONTAINER / INOCULATED BACTEC BOTTLE (AEROBIC PLUS ) | A | To detect and identify the aerobic bacteria causing an infection |
| 12 | 1282VGN | AEROBIC SUSCEPTIBILITY GRAM NEGATIVE ORGANISM | BREAKPOINT MIC BY VITEK | PURE FRESHLY SUB-CULTURED ISOLATE | R | AEROBIC DRUG SUSCEPTIBILITY TEST FOR GRAM NEGATIVE ORGANISM |
| 13 | 1281VGP | AEROBIC SUSCEPTIBILITY GRAM POSITIVE ORGANISM | BREAKPOINT MIC BY VITEK | PURE FRESHLY SUB-CULTURED ISOLATE | R | AEROBIC DRUG SUSCEPTIBILITY TEST FOR GRAM POSITIVE ORGANISM |
| 14 | 1347H | ALANINE AMINOTRANSFERASE (ALT/SGPT), SERUM | SPECTROPHOTOMETRY | SERUM | RED /GEL (30 °C 2 DAYS / 2-8 °C 7 DAYS) | Alanine aminotransferase (ALT) test measures the amount of this enzyme in the blood. ALT is found mainly in the liver, but also in smaller amounts in the kidneys, heart, muscles, and pancreas. It is commonly measured as a part of a diagnostic evaluation of hepatocellular injury, to determine liver health. . AST levels increase during acute hepatitis, sometimes due to a viral infection, ischemia to the liver, chronic hepatitis, obstruction of bile ducts, cirrhosis. |
| 15 | 1510H | ALBUMIN, SERUM | SPECTROPHOTOMETRY | SERUM | RED /GEL (20-25 °C 2.5 MONTH / 2-8°C 5 MONTH) | ALBUMIN, SERUM Human serum albumin is the most abundant protein in human blood plasma. It is produced in the liver. Albumin constitutes about half of the blood serum protein. Low blood albumin levels (hypoalbuminemia) can be caused by: Liver disease like cirrhosis of the liver, nephrotic syndrome, protein-losing enteropathy, Burns, hemodilution, increased vascular permeability or decreased lymphatic clearance,malnutrition and wasting etc. |
| 16 | 3930H | ALKALINE PHOSPHATASE, SERUM | SPECTROPHOTOMETRY | SERUM | RED /GEL (20-25 °C 7 DAYS/ 2-8 °C 7 DAYS) | ALKALINE PHOSPHATASE, SERUM Alkaline phosphatase (ALP) is a protein found in almost all body tissues. Tissues with higher amounts of ALP include the liver, bile ducts, and bone. Elevated Alkaline Phosphaqtase levels are seen in Biliary obstruction,Osteoblastic bone tumors, osteomalacia, hepatitis, Hyperparathyroidism,Leukemia, Lymphoma,Paget””””s disease,Rickets,Sarcoidosis etc. Lower-than-normal ALP levels seen in Hypophosphatasia, Malnutrition, Protein deficiency,Wilson””””s disease . |
| 17 | 3109 | ALPHA-FETOPROTEIN / LIVER CANCER MONITOR | CHEMILUMINESCENCE | SERUM ( Age+Gender+Clinical History ) | 2-8°C (72 hrs); F (> 72 hrs – 15 Days) | Useful For The follow-up of patients undergoing cancer therapy, especially for testicular and ovarian tumors and for hepatocellular carcinoma. Often used in conjunction with human chorionic gonadotropin Clinical Utility Alpha-fetoprotein is a glycoprotein that is produced in early fetal life by the liver and by a variety of tumors including hepatocellular carcinoma, hepatoblastoma, and nonseminomatous germ cell tumors of the ovary and testis (eg, yolk sac and embryonal carcinoma). Concentrations of AFP above the reference range also have been found in serum of patients with benign liver disease (eg, viral hepatitis, cirrhosis), gastrointestinal tract tumors and, along with carcinoembryonic antigen in ataxia telangiectasia. AFP is also elevated in pregnancy Cautions 1. This assay is intended only as an adjunct in the diagnosis and monitoring of AFP-producing tumors. The diagnosis should be confirmed by other tests or procedures. 2. AFP is not recommended as a screening procedure for cancer detection in the general population. 3. Not useful in patients with pure seminoma or dysgerminoma. 4. “Neonates have elevated AFP levels which gradually return to normal by end of first year.” Ranges for newborns are not available and the ranges mentioned in the report are those of adults.(Reference: Blohm ME, Vesterling-Horner D, Calaminus G, et al: Alpha-1-fetoprotein reference values in infants up to 2 years of age. Pediatr Hematol Onco 1998 Mar-April;15(2):135-142). Pregnant females: As per Teitz, 6th ed Weeks of gestation AFP medians (ng/ml) 14 weeks 25.6 15 weeks 29.9 16 weeks 34.8 17 weeks 40.6 18 weeks 47.3 19 weeks 55.3 20 weeks 64.3 21 weeks 74.8 |
| 18 | 1705 | AMH (Anti-Müllerian Hormone)/ Müllerian Inhibiting Substance (MIS) | FLUOROENZYME IMMUNOASSAY | SERUM | 2-8°C (24HRS), F (> 24 HRS) | ANTI-MULLERIAN HORMONE (AMH)/ MULLERIAN INHIBITING SUBSTANCES (MIS) Anti mullerian hormone (AMH) or Mullerian inhibiting substances (MIS) is a glycoprotein dimer composed of two 72 kDa monomers linked by disulfide bonds. AMH belongs to the transforming growth factor ß (TGF – ß) superfamily. AMH is a hormone marker for quantitative prediction of ovarian reserve, ovarian aging, ovarian dysfunction and ovarian responsiveness. The levels of AMH decrease in pre-menopausal women as the quality and number of ovarian follicles decline with age. Clinical Utility: • Evaluating Fertility Potential – Serum AMH levels correlate with the number of early antral follicles with greater specificity than Inhibin B, Oestradiol, Follicle Stimulating Hormone and Luteinizing Hormone on cycle day 3. Thus, Day 3 AMH may reflect ovarian follicular status better than these hormone markers. • Measuring Ovarian Aging – Diminished ovarian reserve, associated with poor response to IVF, is signaled by reduced baseline serum AMH concentrations. AMH would appear to be a useful marker for predicting ovarian aging and the potential for successful IVF. • Predicting Onset of Menopause – The duration of the menopausal transition can vary significantly in individuals and reproductive capacity may be seriously compromised prior to clinical diagnosis. AMH can predict the occurrence of the menopausal transition. • Assessing Polycystic Ovary Syndrome – Serum AMH levels are elevated in patients with polycystic ovary syndrome and may be useful as a marker for the extent of the disease. Interpretation: AMH levels do not change significantly throughout the menstrual cycle and decrease with age. Healthy women, below 38 years old, with normal follicular status at day 3 of the menstrual cycle, have AMH levels of 2.0 – 6.8 ng/ml (14.28 – 48.55 pM). Ovarian Fertility Potential pmol/L ng/mL Optimal Fertility 28.6 – 48.5 4.0 – 6.8 Satisfactory Fertility 15.7 – 28.6 2.2 – 4.0 Low Fertility 2.2 – 15.7 0.3 – 2.2 Very Low / undetectable 0.0 – 2.2 0.0 – 0.3 High Level > 48.5 > 6.8 The interpretation guide provided above are only suggestions which are based upon examination of multiple published studies. It is expected in the near future that refinement of these ranges may occur. References: 1. Durlinger ALL, Visser JA, Themmen APN. Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction 2002; 124:601-609. 2. Ficicioglu C, Kutlu T, Baglam E, Bakacak Z. Early follicular antimüllerian hormone as an indicator of ovarian reserve. Fertility and Sterility 2006; 85:592-6. 3. Human Reproduction 2007 22(9):2414-2421; doi:10.1093/humrep/dem204. 4. Fertil Steril. 2005; 83(4):979-87 (ISSN: 1556-5653) |
| 19 | 3844UHD | AMYLASE, 24HRS URINE | SPECTROPHOTOMETRY | 24HR URINE/RANDOM | URINE CONTAINER (20-25 °C 2 DAYS, 2-8 °C >10DAYS) | AMYLASE, 24HRS URINE Concentration of amylase in urine increases in situations in which serum amylase concentration is elevated, urinary amylase concentration remains elevated up to 7 days after amylase levels have returned to normal, following an attack of pancreatitis. Thus, the determination of urinary amylase may be useful if the patient is seen late in course of an attack of pancreatitis. An elevated serum amylase with normal or low urine amylase excretory rate may be seen in presence of renal insufficiency or with macroamylasemia. |
| 20 | 3844D | AMYLASE, SERUM | SPECTROPHOTOMETRY | SERUM | RED /GEL (20-25 °C 7 DAYS, 2-8 °C 7DAYS) | Amylase levels increase in acute pancreatitis, pseudo- cyst of pancreas, obstruction of pancreatic ducts, mumps, occasionally elevated in renal insufficiency, ruptured ectopic pregnancy, appendicitis, dissecting aortic aneurysm, cerebral trauma, diabetic acidosis and inflammation of pancreas from a perforating peptic ulcer. Rarely, combination of amylase with an immunoglobulin produces elevated serum amylase activity (macro amylasemia) because the large molecular complex is not filtered by the glomerulus. Decrease in amylase level is seen in acute and chronic hepatitis, pancreatic insufficiency, advanced cystic fibrosis, pancreatectomy and occasionally in toxemia of pregnancy. |
| 21 | 1100E | ANA (Anti-nuclear antibody) | Enzyme Linked Immnunosorbent assay | SERUM | FRESH SAMPLE; Ambient REFRIGERETED UPTO 3 DAYS FROZEN > 3 DAYS |
The Immunofluoresence assay is the Gold standard method for ANA testing. A negative ANA test virtually rules out a diagnosis of Systemic Lupus Erythematosus but a positive test may be indicative of a number of autoimmune connective tissue diseases such as Scleroderma, Rheumatoid Arthritis and Sjogren”s syndrome.When correlated with the Clinical history & physical examination ,it identifies almost all pts. With SLE ( Senstivity < 95 % ). Population studies show positive ANA in approximately 1-5 % of healthy subjects. False positive results for ANA can be seen in pts. Taking certain medications like – hydralazine , isoniazid , procainamide etc.ANA test carried out by Immunofluorescence assay using HEP-2 slide (Tissue culture substrate) is more sensitive and specific than ANA carried out by enzyme immunoassay. TITRE ANA positivity of greater than or equal to 1:160 titre is of clinical significance in diagnosis of Collagen Vascular Disorders. Upto 40 % of elderly subjects with chronic non-rheumatological illness have ANA positivity usually at low titre (1: 40 – 1:160) PATTERN The ANA pattern seen on immunofluorescence staining helps in determination of the antibody specificities which need to be confirmed by immunoblot techniques. The positivity seen on fluorescence indicates 1+ positivity = Minimum Immunofluroscence of no significance. 2+ Positivity = Mildly positive, clinically insignificant. 3+ Positivity = Significant positive, needs clinical correlation. 4+ Positivity = Strong positive, highly suggestive of collagen vascular disease. A titre estimation helps to monitor response to treatment. Please refer to the following test codes for specific antibody determination by IMMUNOBLOT # 1220 : Sm(SMITH) antibody # 1215 : U1SNRNP antibody # 1204 : SSA antibody # 1205 : SSB antibody # 1007 : SSA & SSB antibodies # 1235 : Scl – 70 antibody # 1208 : Jo – 1 antibody PLEASE NOTE: ALL ANA RESULTS WILL BE REPORTED WITH FINAL END POINT TITRE VALUE. |
| 22 | 1100R | ANA (Anti-nuclear antibody) R | RAPID AGULATINATION | SERUM | FRESH SAMPLE; Ambient REFRIGERETED UPTO 3 DAYS FROZEN > 3 DAYS |
The Immunofluoresence assay is the Gold standard method for ANA testing. A negative ANA test virtually rules out a diagnosis of Systemic Lupus Erythematosus but a positive test may be indicative of a number of autoimmune connective tissue diseases such as Scleroderma, Rheumatoid Arthritis and Sjogren”s syndrome.When correlated with the Clinical history & physical examination ,it identifies almost all pts. With SLE ( Senstivity < 95 % ). Population studies show positive ANA in approximately 1-5 % of healthy subjects. False positive results for ANA can be seen in pts. Taking certain medications like – hydralazine , isoniazid , procainamide etc.ANA test carried out by Immunofluorescence assay using HEP-2 slide (Tissue culture substrate) is more sensitive and specific than ANA carried out by enzyme immunoassay. TITRE ANA positivity of greater than or equal to 1:160 titre is of clinical significance in diagnosis of Collagen Vascular Disorders. Upto 40 % of elderly subjects with chronic non-rheumatological illness have ANA positivity usually at low titre (1: 40 – 1:160) PATTERN The ANA pattern seen on immunofluorescence staining helps in determination of the antibody specificities which need to be confirmed by immunoblot techniques. The positivity seen on fluorescence indicates 1+ positivity = Minimum Immunofluroscence of no significance. 2+ Positivity = Mildly positive, clinically insignificant. 3+ Positivity = Significant positive, needs clinical correlation. 4+ Positivity = Strong positive, highly suggestive of collagen vascular disease. A titre estimation helps to monitor response to treatment. Please refer to the following test codes for specific antibody determination by IMMUNOBLOT # 1220 : Sm(SMITH) antibody # 1215 : U1SNRNP antibody # 1204 : SSA antibody # 1205 : SSB antibody # 1007 : SSA & SSB antibodies # 1235 : Scl – 70 antibody # 1208 : Jo – 1 antibody PLEASE NOTE: ALL ANA RESULTS WILL BE REPORTED WITH FINAL END POINT TITRE VALUE. |
| 23 | 9206RFX | ANA Reflux ENA | Enzyme Linked Immnunosorbent assay & IMMUNO FLUORESCENT ASSAY | SERUM | 2-8°C (3 DAYS); -20°C (>3 DAYS OR SHIPPED) | ANA is useful in the diagnosis of patients with autoimmune diseases such as SLE, Mixed connective tissue disease, Rheumatoid arthritis, Sjogren’s syndrome, Progressive systemic sclerosis and CREST syndrome. The incidence of low titre ANA positivity increases with age in normal individuals. many drugs like Hydralazine and Procainamide may induce ANA production. |
| 24 | 5708ID | ANAEROBIC BACTERIA IDENTIFICATION | VITEK | PURE CULTURE OF ANAEROBIC ORGANISM IN BACTEC ANAEROBIC BOTTLE | A | Identification of anaerobic organisms is useful in selecting appropriate antibiotic treatment. |
| 25 | 3301 | ANTI – CYCLIC CITRULLINATED PEPTIDE ANTIBODIES (ANTI-CCP) | FLUOROENZYME IMMUNOASSAY | SERUM | 2-8°C (3 DAYS); -20°C (>3 DAYS) | ANTI – CCP ANTIBODIES, SERUM Rheumatoid arthritis (RA) is a systematic autoimmune disease that is multi-functional in origin and is characterized by chronic inflammation of the membrane lining(synovium) joints which commonly leads to progressive joint destruction and in most cases to disability and reduction of quality of life.. The disease spreads from small to large joints, with the greatest damage in early phase. The diagnosis of RA is primarily based on clinical, radiological and immunological features. The most frequent serological test is the measurement of rheumatoid factor (RF). The IgM class is the most common and is found in 60-80% of RA patients. RF is not specific for RA, as it is often present in healthy individuals and patients with other autoimmune diseases and chronic infections. Citrullinated proteins have been discovered in the joints of patients with rheumatoid arthritis but not in other forms of joint disease. The citrullinated proteins in the joints correspond to the presence of the citrulline antibodies in the blood and suggest a possible role for these antibodies in the development of rheumatoid arthritis. Anti-CCP test is used for the detection of the IgG class of autoantibodies specific to cyclic citrullinated peptide (CCP) in human serum or plasma (EDTA). Autoantibody levels represent one parameter in a multi-criterion diagnosis process, encompassing both clinical and laboratory-based assessments. The citrulline antibody appears early in the course of rheumatoid arthritis and is present in the blood of most patients with the disease. When the citrulline antibody is detected in a patient’s blood, there is 90-95% likelihood that the patient has rheumatoid arthritis. The test for the citrulline antibody is therefore useful in the diagnosis of patients with unexplained joint inflammation, especially when the traditional blood test for rheumatoid factor is negative. The citrulline antibody also has prognostic (predictive) value since it is associated with a greater tendency towards more destructive forms of rheumatoid arthritis. Detection of anti -CCP antibodies is used as an aid in the diagnosis of Rheumatoid arthritis(RA) and should be used in conjunction with other clinical information. |
| 26 | 1862C | ANTI NEUTROPHYLIC CYTOPLASMIC ANTIBODIES (C – ANCA) WITH TITRE | Enzyme Linked Immnunosorbent assay | SERUM | 2-8°C (1 WEEK); -20°C (LONGER) | This assay is useful for evaluating patients suspected of having Autoimmune vasculitis, both Wegener’s granulomatosis and Microscopic Polyangiitis. Autoantibodies to PR3 ( cANCA) occur in patients with classical / limited endorgan involvement Wegener’s granulomatosis. Antibodies to MPO (pANCA) occur predominantly in patients with Microscopic Polyangiitis. |
| 27 | 1862P | ANTI NEUTROPHYLIC CYTOPLASMIC ANTIBODIES (P – ANCA) WITH TITRE | Enzyme Linked Immnunosorbent assay | SERUM | 2-8°C (1 WEEK); -20°C (LONGER) | This assay is useful for evaluating patients suspected of having Autoimmune vasculitis, both Wegener’s granulomatosis and Microscopic Polyangiitis. Autoantibodies to PR3 ( cANCA) occur in patients with classical / limited endorgan involvement Wegener’s granulomatosis. Antibodies to MPO (pANCA) occur predominantly in patients with Microscopic Polyangiitis. |
| 28 | 1100CG | ANTI NUCLEAR ANTIBODIES (ANA), QUALITATIVE | LATEX PARTICLE AGGLUTINATION METHOD | SERUM | 2-8°C (48 HRS); -20°C (>48 HRS) | The Immunofluoresence assay is the Gold standard method for ANA testing. A negative ANA test virtually rules out a diagnosis of Systemic Lupus Erythematosus but a positive test may be indicative of a number of autoimmune connective tissue diseases such as Scleroderma, Rheumatoid Arthritis and Sjogren”s syndrome.When correlated with the Clinical history & physical examination ,it identifies almost all pts. With SLE ( Senstivity < 95 % ). Population studies show positive ANA in approximately 1-5 % of healthy subjects. False positive results for ANA can be seen in pts. Taking certain medications like – hydralazine , isoniazid , procainamide etc.ANA test carried out by Immunofluorescence assay using HEP-2 slide (Tissue culture substrate) is more sensitive and specific than ANA carried out by enzyme immunoassay. TITRE ANA positivity of greater than or equal to 1:160 titre is of clinical significance in diagnosis of Collagen Vascular Disorders. Upto 40 % of elderly subjects with chronic non-rheumatological illness have ANA positivity usually at low titre (1: 40 – 1:160) PATTERN The ANA pattern seen on immunofluorescence staining helps in determination of the antibody specificities which need to be confirmed by immunoblot techniques. The positivity seen on fluorescence indicates 1+ positivity = Minimum Immunofluroscence of no significance. 2+ Positivity = Mildly positive, clinically insignificant. 3+ Positivity = Significant positive, needs clinical correlation. 4+ Positivity = Strong positive, highly suggestive of collagen vascular disease. A titre estimation helps to monitor response to treatment. Please refer to the following test codes for specific antibody determination by IMMUNOBLOT # 1220 : Sm(SMITH) antibody # 1215 : U1SNRNP antibody # 1204 : SSA antibody # 1205 : SSB antibody # 1007 : SSA & SSB antibodies # 1235 : Scl – 70 antibody # 1208 : Jo – 1 antibody PLEASE NOTE: ALL ANA RESULTS WILL BE REPORTED WITH FINAL END POINT TITRE VALUE. |
| 29 | 1711T | ANTI PHOSPHOLIPID IgG ANTIBODIES | ENZYME LINKED IMMUNOSORBENT ASSAY | SERUM | 2-8°C (48 hrs.); -20°C (>48 hrs.) | ANTI PHOSPHOLIPID IgG ANTIBODIES Antibodies against phospholipids, components of the biological membranes, are specific for phospholipids such as Cardiolipin, Phosphatidyl-nositol, -enthanolamine, -serine, -choline and Sphingomyelin. Anti-phospholipid antibodies are frequently found in sera of patients with systemic lupus erythematosus (SLE) and related diseases. The occurrence of anti-phospholipid antibodies in patients with SLE and related diseases is typical for a secondary anti-phospholipid syndrome (APS). In contrast, anti-phospholipid antibodies in patients with no other autoimmune diseases characterize the primary APS. Clinical and experimental evidence have shown a correlation between these auto-antibodies and an enhanced incidence of thrombosis, thrombocytopenia and habitual abortions (as a consequence of placental infarct). Obstetric findings, such as recurrent fetal loss, intrauterine growth retardation and pre-eclampsia may occur in 10-20% of women with APS.Positive test results alone are not diagnostic and must be interpreted in conjunction with the patient’s clinical presentation and other serological markers. If the test is positive, it is advised to repeat test after an interval of 12 weeks, for confirmation of APLA syndrome. |
| 30 | 1735 | ANTI PHOSPHOLIPID IgM ANTIBODIES | ENZYME LINKED IMMUNOSORBENT ASSAY | SERUM | 2-8°C (48 hrs.); -20°C (>48 hrs.) | ANTI PHOSPHOLIPID IgG ANTIBODIES Antibodies against phospholipids, components of the biological membranes, are specific for phospholipids such as Cardiolipin, Phosphatidyl-nositol, -enthanolamine, -serine, -choline and Sphingomyelin. Anti-phospholipid antibodies are frequently found in sera of patients with systemic lupus erythematosus (SLE) and related diseases. The occurrence of anti-phospholipid antibodies in patients with SLE and related diseases is typical for a secondary anti-phospholipid syndrome (APS). In contrast, anti-phospholipid antibodies in patients with no other autoimmune diseases characterize the primary APS. Clinical and experimental evidence have shown a correlation between these auto-antibodies and an enhanced incidence of thrombosis, thrombocytopenia and habitual abortions (as a consequence of placental infarct). Obstetric findings, such as recurrent fetal loss, intrauterine growth retardation and pre-eclampsia may occur in 10-20% of women with APS.Positive test results alone are not diagnostic and must be interpreted in conjunction with the patient’s clinical presentation and other serological markers. If the test is positive, it is advised to repeat test after an interval of 12 weeks, for confirmation of APLA syndrome. |
| 31 | 2376R | ANTI STREPTOLYSIN – O ANTIBODIES (ASO) – (RAPID) | QUALATATIVE RAPID | 12 -14 HRS FASTING SERUM + CLINICAL HISTORY + (AGE & GENDER IS MANDATORY) | 2-8°C (8 DAYS); F (>8 -90 DAYS, IF F WITHIN 24 HRS. OF COLLECTION) | Antistreptolysin O is useful in confirming exposure to Streptococcus pyogenes in the absence of other laboratory evidence. |
| 32 | 1332 | ANTISTREPTOLYSIN O QUANTITATIVE (ASO), SERUM | SPECTROPHOTOMETRY | SERUM | RED/GEL | ANTISTREPTOLYSIN O, SERUM ASO is a rapid, latex agglutination, slide test for the detection of Anti-Streptolysin ””0”” in serum. Test Utility: ASO titre may help in determining Streptococcal infection of group A and C. Elevated ASO titres may be associated with Acute glomerulonephritis and Acute Rheumatic Fever.Group”” A”” Streptococcal infections are common in school age children. Limitations: Testing the single specimen has relatively limited value. Testing of successive serum samples taken at intervals of 10 to 14 days, with at least four fold rise in titre is generally indicative of recent infection. |
| 33 | 1110 | ANTI-THYROGLOBULIN ANTIBODIES (aTG) | Enzyme Linked Immnunosorbent assay | SERUM | 2-8°C (48 hrs); F (>48 hrs) | High levels of anti-Thyroglobulin antibodies are seen in sera of patients with thyroid disorders such as Chronic Lymphocytic (Hashimoto””s) Thyroiditis (76 – 100%), Primary Myxedema (72%), Hyperthyroiditis (33%), Colloid Goitre (8%) & Adenomata (28%).Positive thyroid autoantibody levels in patients with high-normal or slightly elevated serum thyrotropin levels predict the future development of more profound hypothyroidism. Low titers of thyroid autoantibodies may be observed in the absence of autoimmune or other thyroid diseases and are considered a nonspecific finding. |
| 34 | 3062 | ANTI-THYROID PEROXIDASE ANTIBODIES (aTPO) / ANTI MICROSOMAL ABS | CHEMILUMINESCENCE | SERUM ( Age+Gender mandatory) | 2-8°C (48 hrs); F (>48 hrs) | Anti-thyroid peroxidase (anti-TPO) antibodies are specific for the autoantigen TPO, a 105kDa glycoprotein that catalyses iodine oxidation and thyroglobulin tyrosyl iodination reactions in the thyroid gland. Anti-TPO antibodies are the most common anti-thyroid autoantibody, present in approximately 90% of Hashimoto””””””””s thyroiditis, 75% of Graves”””””””” disease and 10-20% of nodular goitre or thyroid carcinoma. It is considered as the gold standard for diagnosis of Chronic Autoimmune (Hashimoto) Thyroiditis. Also, 10-15% of normal individuals can have high level anti-TPO antibody titres.High serum antibodies are found in active phase chronic autoimmune thyroiditis. Thus, antibody titer can be used to assess disease activity in patients that have developed such antibodies. |
| 35 | 7697 | ARTERIAL BLOOD GAS (ABG) | ELECTROCHEMICAL METHOD | HEPARIN ARTERIAL BLOOD | HEPARIN GREEN TOP TUBE | An arterial blood gas (ABG) test measures the acidity (pH) and the levels of oxygen and carbon dioxide in the blood from an artery. This test is used to check how well your lungs are able to move oxygen into the blood and remove carbon dioxide from the blood. |
| 36 | 5194 | ASCITIC FLUID, ROUTINE | SPECTROPHOTOMETRY / MICROSCOPY | FLUID | STERILE CONTAINER | To help diagnose the cause of peritonitis, an inflammation of the membrane lining the abdomen, and/or peritoneal fluid accumulation, where fluid builds up in the abdomen or around internal organs (called ascites) |
| 37 | 1345H | ASPARTATE AMINOTRANSFERASE (AST/SGOT), SERUM | SPECTROPHOTOMETRY | SERUM | RED /GEL | Aminotransferase (AST) is an enzyme found in various parts of the body .AST is found in the liver, heart, skeletal muscle, kidneys, brain, and red blood cells, and it is commonly measured clinically as a marker for liver health. AST levels increase during chronic viral hepatitis, blockage of the bile duct, cirrhosis of the liver, liver cancer, kidney failure, hemolytic anemia, pancreatitis, hemochromatosis. AST levels may also increase after a heart attack or strenuous activity. |
| 38 | 1589 | BENCE-JONES PROTEIN | CHEMICAL ANALYSIS | 24HRS URINE WITHOUT PRESERVATIVE & REFRIGERATE DURING COLLECTION OR RANDOM URINE WITHOUT PRESERVATIVE. (CLINICAL HISTORY + AGE & GENDER IS MANDATORY) | F | Bence Jones protein is a monoclonal globulin or immunoglobulin light chain found in the urine, with a molecular weight of 2224 kDa. Detection of Bence Jones protein may be suggestive of Multiple myeloma or Waldenström’s macroglobulinemia |
| 39 | 3143 | BETA-2-MICROGLOBULIN | CHEMILUMINESCENCE | SERUM (CLINICAL HISTORY REQUIRED) | 2-8°C (7 days); F (2 Weeks) | This assay is useful for evaluating prognosis of Multiple myeloma. It is also used for the evaluation of Renal tubular disorders where serum levels are low but urine levels are high. |
| 40 | 3184 | BETA-HUMAN CHORIONIC GONADOTROPIN, (BETA hCG) | CHEMILUMINESCENCE | SERUM ( AGE + GENDER + LMP + CLINICAL HISTORY REQUIRED ) | 2-8°C (7 days); F (2 Months) | HCG is a glycoprotein hormone that consists of 2 subunits (alpha and beta chains), which are associated to comprise the intact hormone. HCG is produced in the placenta during pregnancy. In nonpregnant women, it can also be produced by tumors of the trophoblast, germ cell tumors with trophoblastic components, and some nontrophoblastic tumors. Elevated hCG concentrations are also found in patients with other diseases such as tumors of the ovaries, bladder, pancreas, stomach, lungs, and liver The biological action of hCG serves to maintain the corpus luteum during pregnancy. Measurement of the hCG concentration permits the diagnosis of pregnancy as early as 1 week after conception. Elevated concentrations of hCG measured in the first trimester of pregnancy are observed in normal pregnancy, but may serve as an indication of chorionic carcinoma, hydatiform mole, or multiple pregnancy. Decreasing hCG concentrations indicate threatened or missed abortion, recent termination of pregnancy, ectopic pregnancy, or intrauterine death. Both normal and ectopic pregnancies generally yield positive results of pregnancy tests. The comparison of quantitative hCG measurements with the results of transvaginal ultrasonography may aid in the diagnosis of ectopic pregnancy. |
| 41 | 1527H | BILIRUBIN (TOTAL, DIRECT, INDIRECT), SERUM | SPECTROPHOTOMETRY | SERUM | GEL/RED (20-25 °C 1 DAY / 2-8 °C 7 DAYS)- PROTECT FROM SUNLIGHT | :BILIRUBIN (TOTAL, DIRECT, INDIRECT), SERUM Bilirubin is a yellowish pigment found in bile and is a breakdown product of normal heme catabolism. Bilirubin is excreted in bile and urine, and elevated levels may give yellow discoloration in jaundice.Elevated levels results from increased bilirubin production (eg, hemolysis and ineffective erythropoiesis), decreased bilirubin excretion (eg, obstruction and hepatitis), and abnormal bilirubin metabolism (eg, hereditary and neonatal jaundice). Conjugated (direct) bilirubin is elevated more than unconjugated (indirect) bilirubin in Viral hepatitis, Drug reactions, Alcoholic liver disease Conjugated (direct) bilirubin is also elevated more than unconjugated (indirect) bilirubin when there is some kind of blockage of the bile ducts like in Gallstones getting into the bile ducts, tumors & Scarring of the bile ducts. Increased unconjugated (indirect) bilirubin may be a result of Hemolytic or pernicious anemia, Transfusion reaction & a common metabolic condition termed Gilbert syndrome, due to low levels of the enzyme that attaches sugar molecules to bilirubin. Total Bili- Source: Wallach”s Interpretation of Diagnostic tests, 9th ed Direct Bili – Source: Tietz Text book of Clinical Chemistry & Molecular Diagnostics, 4th ed d |
| 42 | 1526H | BILIRUBIN, DIRECT, SERUM | SPECTROPHOTOMETRY | SERUM | RED/ GEL (20-25 °C 1 DAY / 2-8 °C 7 DAYS)- PROTECT FROM SUNLIGHT | BILIRUBIN, DIRECT, SERUM Conjugated (direct) bilirubin is elevated more than unconjugated (indirect) bilirubin in Viral hepatitis, Drug reactions, Alcoholic liver disease Conjugated (direct) bilirubin is also elevated more than unconjugated (indirect) bilirubin when there is some kind of blockage of the bile ducts like in Gallstones getting into the bile ducts, tumors & Scarring of the bile ducts. Source: Tietz Text book of Clinical Chemistry & Molecular Diagnostics, 4th ed |
| 43 | 1088H | BILIRUBIN, TOTAL, SERUM | SPECTROPHOTOMETRY | SERUM | RED (20-25 °C 1 DAY / 2-8 °C 7 DAYS)- PROTECT FROM SUNLIGHT | Bilirubin is a yellowish pigment found in bile and is a breakdown product of normal heme catabolism. Bilirubin is excreted in bile and urine, and elevated levels may give yellow discoloration in jaundice.Elevated levels results from increased bilirubin production (eg, hemolysis and ineffective erythropoiesis), decreased bilirubin excretion (eg, obstruction and hepatitis), and abnormal bilirubin metabolism (eg, hereditary and neonatal jaundice). An elevated bilirubin level in a newborn may be temporary and resolve itself within a few days to two weeks. However, if the bilirubin level is above a critical threshold or rapidly increases, an investigation of the cause is needed so appropriate treatment can be initiated. Source: Wallach”s Interpretation of Diagnostic tests, 9th ed |
| 44 | 1089 | BLEEDING TIME | MANUAL | OTHERS | OTHERS | A bleeding time evaluation is used to measure the primary phase of hemostasis, which involves platelet adherence to injured capillaries and then platelet activation and aggregation. The bleeding time can be abnormal when the platelet count is low or the platelets are dysfunctiona |
| 45 | 1389CO | BLOOD COAGULATION PROFILE | COAGULOMETER , MICROSCOPY/ 5 PART AUTOANALYSER, MANUAL | FROZEN CITRATE PPP AT -20 C , EDTA WHOLE BLOOD , SMEARS | CITRATE TUBE , BLUE TOP. RT 2 HR ;4°C 4 HR; -20 for 2 WEEK , SMEARS | A coagulation profile (coags) includes INR, APTT, platelets and fibrinogen. It is a screening test for abnormal blood clotting because it examines the factors most often associated with a bleeding problem. It does not cover all causes of bleeding tendencie |
| 46 | 5190 | BRONCHOALVEOLAR FLUID ANALYSIS | MANUAL/ CYTOSPIN | FLUID | STERILE CONTAINER | The data suggest that cellular analysis of BAL fluid is a rapid and useful technique for differentiating bacterial pneumonia from viral pneumonia, and can be used to direct early appropriate treatment. |
| 47 | 8831R | BRUCELLA ANTIBODIES (RAPID), SERUM | RAPID | SERUM | 2-8º C (2 days), >2 days- 20 °C | Brucellosis is caused by gram negative bacillus of genus Brucella either by direct contact or by ingestion of meat or milk. In cases of suspected Brucellosis, this assay assists in the diagnosis and plays a supplementary role to routine culture. |
| 48 | 8831 | BRUCELLA IGG & IGM ANTIBODIES (ELISA), SERUM | Enzyme Linked Immnunosorbent assay | SERUM | 2-8°C (2DAYS); -20°C (>2DAYS) | Brucellosis is caused by gram negative bacillus of genus Brucella either by direct contact or by ingestion of meat or milk. In cases of suspected Brucellosis, this assay assists in the diagnosis and plays a supplementary role to routine culture. |
| 49 | 8831G | BRUCELLA IGG ANTIBODIES (ELISA), SERUM | Enzyme Linked Immnunosorbent assay | SERUM | 2-8º C (2 days), >2 days- 20 °C | Brucellosis is caused by gram negative bacillus of genus Brucella either by direct contact or by ingestion of meat or milk. In cases of suspected Brucellosis, this assay assists in the diagnosis and plays a supplementary role to routine culture. |
| 50 | 8831M | BRUCELLA IgM ANTIBODIES (ELISA), SERUM | Enzyme Linked Immnunosorbent assay | SERUM | 2-8º C (2 days), >2 days- 20 °C | Brucellosis is caused by gram negative bacillus of genus Brucella either by direct contact or by ingestion of meat or milk. In cases of suspected Brucellosis, this assay assists in the diagnosis and plays a supplementary role to routine culture. |
| 51 | 1535H | C REACTIVE PROTEIN (CRP, SEMI QUANTITATIVE) | LATEX AGGLUTINATION METHOD | SERUM | RED /GEL 2-8°C (48 HRS) | C-REACTIVE PROTEIN, SERUM (QUANTITATIVE) CRP is one of the proteins commonly referred to as acute phase reactants. CRP is distinguished by its rapid response to trauma or infection. Elevated levels of CRP may be seen in inflammatory disorders, tissue injury or necrosis and infections. Synthesis of CRP increases within 4-6 hours of onset of inflammation, reaching peak values within 1-2 days. CRP levels also fall quickly after resolution of inflammation since its half life is 6 hours. Testing for CRP is indicated in the following clinical situations – monitoring recovery from surgery, myocardial infarction, transplantation, inflammatory bowel disease, rheumatic diseases and infectious diseases. Measuring and charting C-reactive protein values can also prove useful in determining disease progress or the effectiveness of treatments. CRP levels in autoimmune diseases may show little or no increase unless infection is present. Levels may not increase in conditions like pregnancy, angina, seizures, asthma, common cold. The main limitation of CRP is in its non-specific response and should not be interpreted without a complete clinical history and evaluation. |
| 52 | 3121 | CA 125 / OVARIAN CANCER MONITOR | CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY (CMIA) | SERUM | 2-8°C (7 DAYS); -20°C (>7 DAYS) | CA 125 is a surface antigen, identified as a 200-1000 kDa mucin-like glycoprotein associated with non-mucinous epithelial ovarian malignancy. CA 125 is a useful tumor marker for evaluating therapy and monitoring disease status in patients under treatment for ovarian cancer. Measured serially the levels of CA 125 correspond with disease progression or regression. The rate of change in CA 125 is also highly prognostic. As a diagnostic tool however, the level of CA 125 alone is not sufficient to determine the presence or extent of disease. Levels of CA 125 should not be interpreted as absolute evidence of the presence or the absence of malignant diseases. Before treatment, patients with confirmed ovarian carcinoma frequently have levels of CA 125 within the range observed in healthy individuals. Preoperative levels of CA 125 in patients with malignant pelvic masses provide no information regarding the histological grade or diameter of the tumor mass. Elevated levels of CA 125 can be observed in patients with nonmalignant diseases. Patients with certain benign conditions, such as hepatic cirrhosis, acute pancreatitis, endometriosis, pelvic inflammatory disease, menstruation and first trimester pregnancy show elevated levels of CA 125. Elevated levels are also found in 1 to 2% of healthy donors. Measurements of CA 125 should always be used in conjunction with other diagnostic procedures, including information from the patient””s clinical evaluation. The concentration of CA 125 in a given specimen determined with assays from different manufacturers can vary due to differences in assay methods, calibration, and reagent specificity. Values obtained with different assay methods cannot be used interchangeably. Heterophilic antibodies in human serum can react with reagent immunoglobulins, interfering with in vitro immunoassays. Patients routinely exposed to animals or to animal serum products can be prone to this interference and anomalous values may be observed. |
| 53 | 3134 | CA 15.3 (Cancer antigen) / BREAST CANCER MONITOR | CHEMILUMINESCENCE | SERUM ( CLINICAL HISTORY REQUIRED ) | 2-8°C (24HRS); F (>24 HRS) | CA 15-3 is a circulating tumor marker, which is useful in monitoring the clinical course of breast cancer patients.Whereas, elevated levels are only present in a small percentage of patients with localized disease, two thirds of the cases with metastatic disease will have significantly elevated levels. CA 15-3, which can monitor response to therapy and can indicate disease status, is a valuable tool in the management of patients with metastases. It can be used for serial measurements to monitor both the course of disease and response to therapy because of the direct correlation of changing levels of CA 15-3 with clinical status.In patients with known metastases, a reduction in levels of this marker indicates a good response to treatment, while increasing levels indicate resistance to therapy and progressive disease and justify further clinical evaluation and regular monitoring. It has also recently been shown that an elevation of CA 15-3 levels above the upper limit of normal in patients with no clinical evidence of disease is an early indicator of recurrence. An elevated serum CA 15-3 level in Stage II or III breast cancer patients in remission provided a positive predictive value of 83.3% for recurrent disease, with an average lead-time of 5.3 months before recurrence was clinically established. The concentration of CA 15-3 in a given specimen, as determined by assays from different manufacturers, can vary due to differences in assay methods and reagent specificity. Values obtained with different assay method cannot be used interchangeably. Heterophilic antibodies in human serum can react with reagent immunoglobulins, interfering with in vitro immunoassays. Patients routinely exposed to animals or to animal serum products can be prone to this interference and anomalous values may be observed. |
| 54 | 3120 | CA 19.9 (Cancer antigen) / PANCREATIC CANCER MONITOR | CHEMILUMINESCENCE | SERUM ( CLINICAL HISTORY REQUIRED ) | 2-8°C (48 hrs); F (>48 hrs) | CA 19-9 has been shown to be a sensitive and specific marker of pancreatic cancer. Very little of the antigen is found in the blood of normal patients or those with benign disorders, but most patients with pancreatic cancer have elevated levels of CA 19-9. CA 19-9 also detects, in decreasing frequency, bile duct, hepatocellular, gastric, colonic, esophageal and non-gastrointestinal cancer. Although elevated levels of CA 19-9 are not distinctively characteristic of pancreatic cancer, it is currently the single most useful blood test in differentiating benign from malignant pancreatic disorders.When used serially, levels of CA 19-9 can predict recurrence of the disease prior to radiographic or clinical findings. Serum levels of Ca 19-9 should not be interpreted as absolute evidence of the presence or the absence of malignant disease. Before treatment, patients with confirmed GI carcinoma frequently have levels of CA 19-9 within the range observed in healthy individuals. Additionally elevated levels of CA 19-9 can be observed in patients with non-malignant diseases. Measurement of CA 19-9 should always be used in conjunction with other diagnostic procedures, including information from patient”s clinical evaluation. The concentration of CA 19-9 in a given specimen, as determined by assays from different manufacturers, can vary due to differences in assay methods and reagent specificity. Values obtained with different assay method cannot be used interchangeably. Heterophilic antibodies in human serum can react with reagent immunoglobulins, interfering with in vitro immunoassays. Patients routinely exposed to animals or to animal serum products can be prone to this interference and anomalous values may be observed. |
| 55 | 4830 | CALCIUM IONISED, SERUM | ELECTROCHEMICAL METHOD | HEPARIN VENOUS / ARTERIAL BLOOD | HEPARIN GREEN TOP TUBE | Commom causes of decreased value of calcium (hypocalcemia) are chronic renal failure, hypomagnesemia and hypoalbuminemia. Hypercalcemia (increased value of calcium) can be caused by increased intestinal absorbtion (vitamin d intoxication), increased skeletal reasorption (immobilization), or a combination of mechanisms (primary hyperparathyroidism). Primary hyperparathyroidism and malignancy accounts for 90-95% of all cases of hypercalcemia. Values of total calcium is affected by serum proteins, particularly albumin thus, latter’s value should be taken into account when interpreting serum calcium levels. The following regression equation may be helpful. Corrected total calcium (mg/dl)= total calcium (mg/dl) + 0.8 (4- albumin [g/dl])* because regression equations vary among group of patients in different physiological and pathological conditions, mathematical corrections are only approximations. The possible mathematical corrections should be replaced by direct determination of free calcium by ISE (available with srl) a common and important source of preanalytical error in the measurement of calcium is prolonged torniquet application during sampling. Thus, this along with fist clenching should be avoided before phlebotomy. |
| 56 | 4836UH | CALCIUM, 24HRS URINE | SPECTROPHOTOMETRY | 24HR URINE/RANDOM | 1-2 ML 6 MOL/L HCL/2 LITER CLEAN BOTTLE (WITH 6 MOL/ LIT 20-30 ML HCL) | To detect hypo/ hypercalcemia in urineCALCIUM, 24HR URINE Test method: Spectrophotometry O-cresolphthalein complexone |
| 57 | 4836H | CALCIUM, SERUM | SPECTROPHOTOMETRY | SERUM | RED /GEL ( 2-8°C <7 DAYS/ -20 °C IF > 7 DAYS) | Commom causes of decreased value of calcium (hypocalcemia) are chronic renal failure, hypomagnesemia and hypoalbuminemia. Hypercalcemia (increased value of calcium) can be caused by increased intestinal absorbtion (vitamin d intoxication), increased skeletal reasorption (immobilization), or a combination of mechanisms (primary hyperparathyroidism). Primary hyperparathyroidism and malignancy accounts for 90-95% of all cases of hypercalcemia. Values of total calcium is affected by serum proteins, particularly albumin thus, latter’s value should be taken into account when interpreting serum calcium levels. The following regression equation may be helpful. Corrected total calcium (mg/dl)= total calcium (mg/dl) + 0.8 (4- albumin [g/dl])* because regression equations vary among group of patients in different physiological and pathological conditions, mathematical corrections are only approximations. The possible mathematical corrections should be replaced by direct determination of free calcium by ISE (available with srl) a common and important source of preanalytical error in the measurement of calcium is prolonged torniquet application during sampling. Thus, this along with fist clenching should be avoided before phlebotomy. |
| 58 | 3258 | CARCINOEMBRYONIC ANTIGEN (CEA) | CHEMILUMINESCENCE | SERUM ( CLINICAL HISTORY REQUIRED ) | 2-8°C (48 HRS); F (>48 HRS) | Carcinoembryonic antigen (CEA) is a glycoprotein and belongs to a group of tumor markers referred to as oncofetal proteins. Increased serum CEA levels have been detected in persons with primary colorectal cancer and in patients with other malignancies including cancers of the gastrointestinal tract, breast, lungs, ovaries, prostate, liver and pancreas. Elevated serum CEA levels have also been detected in patients with non-malignant disease, especially patients who are older or in smokers. CEA levels are not useful in screening the general population for undetected cancers. However, CEA levels provide important information about patient prognosis, recurrence of tumors after surgical removal and effectiveness of therapy. Serial CEA levels are useful in monitoring the course of disease. CEA levels generally fall to normal or near normal levels within 1 to 4 months after surgical removal of cancerous tissue. A rise in CEA levels may be the first indication of recurrence and may precede physical signs and symptoms. Serial CEA levels are also useful in assessing the effectiveness of therapy or possible metastasis. CEA is a useful tool for monitoring and managing cancer therapy and provides the clinician with additional information about patient prognosis.The concentration of CEA in a given specimen, as determined by assays from different manufacturers, can vary due to differences in assay methods and reagent specificity. Values obtained with different assay method cannot be used interchangeably.Heterophilic antibodies in human serum can react with reagent immunoglobulins, interfering with in vitro immunoassays. Patients routinely exposed to animals or to animal serum products can be prone to this interference and anomalous values may be observed. |
| 59 | 3393 | CARDIAC TROPONIN I (C TnI -QUANTITATIVE) | FLUOROENZYME IMMUNOASSAY / CHEMILUMINESCENCE |
SERUM ( Age+Gender mandatory) | 2-8°C (24 HRS); F (1 Month) | Troponin I is a cardiac marker elevated only in patients suffering from acute Myocardial Infarction. Patients with renal disease or acute muscle injury show normal levels.High sensitivity assays can detect elevated levels of Troponin I (above the 99th percentile of an apparently healthy reference population) within 3 hours after the onset of chest pain. |
| 60 | 3371G | CARDIOLIPIN IgG ANTIBODIES | Enzyme Linked Immnunosorbent assay | SERUM | 2-8°C (48 hrs); -20°C (>48 hrs) | CARDIOLIPIN ANTIBODIES, SERUM Antibodies against Cardiolipin belong to the group of anti-phospholipid antibodies specific for negatively charged phospholipids, components of biological membranes. These antibodies are important as a diagnostic marker for a disorder called the “anti phospholipid syndrome” (APS). Measurement of antibodies to Cardiolipin is useful in the evaluation of patients suspected of having APS including patients with unexplained thrombosis, recurrent pregnancy loss (usually in the 2nd or 3rd trimester), or Furthermore, anti-cardiolipin antibodies have been found in some non-thrombotic neurological disorders like cerebro-vascular insufficiency, cerebral ischemia or chorea and in myocardial infarction. Anti-cardiolipin autoantibodies can be of any combination of the IgM and IgG classes. IgG antibodies are the most prevalent class of autoantibody and the class with the greatest clinical correlation. Samples found to have IgG levels in the ”high” anti-cardiolipin band are most likely to display overt clinical symptoms. Maximum specificity for the diagnosis of APS occurs in patients with positive anti-cardiolipin antibody test results and a positive evaluation for lupus anticoagulant activity. Anti-cardiolipin antibodies are the most commonly measured anti-phospholipid antibodies. However, it is known that some patients with infectious diseases, systemic rheumatic diseases, other autoimmune disorders and some drug-induced disorders show some antibody activity against cardiolipin. Test method: Enzyme Immuno-Assay. |
| 61 | 3371 | CARDIOLIPIN IgM & IgM ANTIBODIES | Enzyme Linked Immnunosorbent assay | SERUM | 2-8°C (48 hrs); -20°C (>48 hrs) | These antibodies are important as a diagnostic marker for a disorder called the “anti phospholipid syndrome”(APS) |
| 62 | 3371M | CARDIOLIPIN IgM ANTIBODIES | Enzyme Linked Immnunosorbent assay | SERUM | 2-8°C (48 hrs); -20°C (>48 hrs) | These antibodies are important as a diagnostic marker for a disorder called the “anti phospholipid syndrome”(APS). |
| 63 | 5111 | CBC, ESR WITH PERIPHERAL SMEAR, EDTA WHOLE BLOOD | 5 PART AUTOANALYSER | EDTA WHOLE BLOOD , CITRATE WHOLE BLOOD | EDTA , BLACK TOP . EDTA: 2-8 °C 24 HR | To determine your general health status; to screen for, diagnose, or monitor any one of a variety of diseases and conditions that affect blood cells, such as anemia,infection, cancer etc |
| 64 | 5110G | CBC-5 PART, EDTA WHOLE BLOOD | 5 PART AUTOANALYSER | EDTA WHOLE BLOOD | EDTA . 2-8 °C 24 HR | To determine your general health status; to screen for, diagnose, or monitor any one of a variety of diseases and conditions that affect blood cells, such as anemia, infection, inflammation, bleeding disorder or cancer |
| 65 | 5195 | CEREBROSPINAL FLUID, ROUTINE ANALYSIS | SPECTROPHOTOMETRY / MICROSCOPY | FLUID | STERILE CONTAINER | To diagnose a disease or condition affecting the central nervous system such as infection. |
| 66 | 1182UHD | CHLORIDE, 24HRS URINE | IMT | 24HR URINE/RANDOM | URINE CONTAINER . 20-25 °C 7 DAYS / 2-8 °C 7 DAYS | An indicator of fluid balance and acid-base homeostasis |
| 67 | 1182HD | CHLORIDE, SERUM | IMT | SERUM | RED /GEL. 20-25 °C 7 DAYS / 2-8 °C 7 DAYS | An indicator of fluid balance and acid-base homeostasis |
| 68 | 3350HD | CHOLESTEROL TOTAL, SERUM | SPECTROPHOTOMETRY | SERUM | RED /GEL (20-25 °C 2 DAYS) | Serum cholesterol is a blood test that can provide valuable information for the risk of coronary artery disease |
| 69 | 1081 | CLOTTING TIME, BLOOD | MANUAL | OTHERS | OTHERS | Partial thromboplastin time and prothrombin time are often done at the same time to check for bleeding problems or the chance for too much bleeding in surgery. Blood clotting factors are needed for blood to clot (coagulation) |
| 70 | 1120 | COOMBS DIRECT TEST | TUBE AGGLUTINATION | WB-EDTA MANDATORY | 2-8°C (48 HRS),>48 HRS -20 °C | Indirect Coombs Test is used to identify red blood cell IgG antibodies that can cross the placenta and cause Hemolytic disease of the newborn. |
| 71 | 1121 | COOMBS INDIRECT TEST | TUBE AGGLUTINATION | SERUM MANDATORY | 2-8°C (48 HRS),>48 HRS -20 °C | Direct Coombs test detects IgG and Complement bound to erythrocytes. The test is useful in diagnosing patients with Hemolytic disease of the newborn and Autoimmune Hemolytic Anemia. Drug induced antibodies may give false positive reactions. |
| 72 | 3128 | CORTISOL | CHEMILUMINESCENCE | SERUM HAS TO BE COLLECTED BETWEEN 7:00-9:00 AM AND 3:00-5:00 PM. (CLINICAL HISTORY AND COLLECTION TIME REQUIRED ) | 2-8°C (48 HRS); F (>48 HRS) | Total cortisol concentrations are decreased in Addison’s disease and increased in Cushing’s disease and in other conditions of glucocorticoid excess. |
| 73 | 3128U | CORTISOL FREE, Urine | CHEMILUMINESCENCE | URINE -24 HRS, TO BE STORED IN REFRIGERATED CONDITION DURING COLLECTION (WITHOUT PRESERVATIVE) (CLINICAL HISTORY AND 24 HRS VOLUME REQUIRED) | 2-8°C (48 HRS); F (>48 HRS) | This assay is preferred as a screening test for Cushing syndrome. It also helps in the diagnosis of Pseudohyperaldo steronism due to excessive licorice consumption. The test has limited usefulness in the evaluation of Adrenal insufficiency. |
| 74 | COVID | COVID 19 | REAL TIME PCR | NASAL SWAB / THROAT SWAB | A | This is a sensitive PCR assay for the detection of COVID 19 |
| 75 | 3140 | C-PEPTIDE | CHEMILUMINESCENCE | FASTING SERUM (FREEZE SERUM SPECIMEN IMMEDIATELY AFTER SEPARATION) CLINICAL HISTORY REQUIRED | FROZEN: UP TO 2 WEEKS | CPeptide is useful in distinguishing Insulinomas from exogenous insulin administration. It’s concentrations are severely decreased or absent in Type I Diabetes mellitus. CPeptide is also useful in monitoring patients who have received islet cell or pancreatic transplants. |
| 76 | 1535N | C-REACTIVE PROTEIN (CRP) QUANTITATIVE, SERUM | SPECTROPHOTOMETRY | SERUM | 2-8°C (8 DAYS); F (> 8 DAYS- 8 MONTHS, IF F WITHIN 24 HRS. OF COLLECTION) | C-REACTIVE PROTEIN, SERUM (QUANTITATIVE) CRP is one of the proteins commonly referred to as acute phase reactants. CRP is distinguished by its rapid response to trauma or infection. Elevated levels of CRP may be seen in inflammatory disorders, tissue injury or necrosis and infections. Synthesis of CRP increases within 4-6 hours of onset of inflammation, reaching peak values within 1-2 days. CRP levels also fall quickly after resolution of inflammation since its half life is 6 hours. Testing for CRP is indicated in the following clinical situations – monitoring recovery from surgery, myocardial infarction, transplantation, inflammatory bowel disease, rheumatic diseases and infectious diseases. Measuring and charting C-reactive protein values can also prove useful in determining disease progress or the effectiveness of treatments. CRP levels in autoimmune diseases may show little or no increase unless infection is present. Levels may not increase in conditions like pregnancy, angina, seizures, asthma, common cold. The main limitation of CRP is in its non-specific response and should not be interpreted without a complete clinical history and evaluation. |
| 77 | 3615D | CREATINE KINASE – MB | CHEMILUMINESCENCE | SERUM (CLINICAL HISTORY + AGE & GENDER IS MANDATORY) AVOID LIPEMIC & HEMOLYSED SPECIMEN | 2-8°C (1 DAY); F (> 1 DAY- 1 MONTH) | CPK is an enzyme found primarily in skeletal and cardiac muscle. Drugs, infections and other diseases may cause injury or inflammation of muscle releasing CPK into the circulation. |
| 78 | 3976H | CREATINE KINASE (CPK), SERUM | SPECTROPHOTOMETRY | SERUM | RED /GEL (20-25 °C 2 DAYS) | Creatine phosphokinase is an enyme found mainly in heart, brain & skeletal muscle. It has 3 isoenzymes – CPK-1 ( CPK-BB ) mostly found in brain & lungs, CPK-2 ( CPK-MB ) mostly found in heart, CPK-3 ( CPK-MM ) found mostly in skeletal muscle. CPK is usually elevated in Brain tumors, Brain injury (stroke), pulmonary infarction, myocardial infarction, crush injuries, Rhabdomyolysis, muscular dystrophy, myositis etc. |
| 79 | 1320UHB | CREATININE (SPOT URINE) | SPECTROPHOTOMETRY | URINE | URINE CONTAINER . 20-25 °C 7 DAYS / 2-8 °C 7 DAYS | CREATININE CLEARANCE Abnormal results (lower than normal creatinine clearance) may indicate: • Kidney damage • Kidney failure • Reduced blood flow to the kidneys • Loss of body fluids (dehydration) • Bladder outlet obstruction • Heart failure |
| 80 | 1322 | CREATININE CLEARANCE, SERUM AND URINE | SPECTROPHOTOMETRY | SERUM | RED /GEL 20-25 °C 7 DAYS (URINE 2 DAYS) / 2-8 °C 7 DAYS (URINE 6 DAYS) | Abnormal results (lower than normal creatinine clearance) may indicate: • Kidney damage • Kidney failure • Reduced blood flow to the kidneys • Loss of body fluids (dehydration) • Bladder outlet obstruction • Heart failure |
| 81 | 1320HGFR | CREATININE EGFR | SPECTROPHOTOMETRY | SERUM | RED /GEL 20-25 °C 7 DAYS / 2-8 °C 7 DAYS | CREATININE, SERUM Higher than normal level may be due to: • Blockage in the urinary tract • Kidney problems, such as kidney damage or failure, infection, or reduced blood flow • Loss of body fluid (dehydration) • Muscle problems, such as breakdown of muscle fibers • Problems during pregnancy, such as seizures (eclampsia)), or high blood pressure caused by pregnancy (preeclampsia) Lower than normal level may be due to: • Myasthenia Gravis • Muscular dystrophy |
| 82 | 3611 | CREATININE KINASE -MUSCLE BRAIN (CK-MB) | CHEMILUMINESCENCE | SERUM [Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration] + Clinical History |
FROZEN: 3 MONTHS | Elevated levels of CPKMB occur 4 to 6 hours after the onset of pain in myocardial infarction, peak at 18 to 24 hours and persist upto 72 hours. It may also be elvated in cases of Carbon monoxide poisoning, Pulmonary embolism, Hypothyroidism, Crush injuries and Muscular dystrophy. |
| 83 | 1320UH | CREATININE, 24HRS URINE | SPECTROPHOTOMETRY | 24HR URINE/RANDOM | 20-25 °C (URINE 2 DAYS) / 2-8 °C (URINE 6 DAYS) | Abnormal results of urine creatinine may be due to any of the following: • High meat diet • Kidney damage • Kidney failure • Reduced blood flow to the Kidneys • Kidney infection • Muscle breakdown or loss of muscle tissue • Urinary tract obstruction |
| 84 | 1320H | CREATININE, SERUM | SPECTROPHOTOMETRY | SERUM | RED /GEL 20-25 °C 7 DAYS / 2-8 °C 7 DAYS | Higher than normal level may be due to: • Blockage in the urinary tract • Kidney problems, such as kidney damage or failure, infection, or reduced blood flow • Loss of body fluid (dehydration) • Muscle problems, such as breakdown of muscle fibers • Problems during pregnancy, such as seizures (eclampsia)), or high blood pressure caused by pregnancy (preeclampsia)Lower than normal level may be due to: • Myasthenia Gravis • Muscular dystrophy |
| 85 | 1212NP | CULTURE – BACTEC – ANAEROBIC CULTURE BLOOD | BACTEC FLUORESCENT METHOD | INOCULATED BACTEC BOTTLE (ANAEROBIC PLUS ) | A | CULTURE; SPUTUM Examination of the sputum remains the mainstay of the evaluation of a patient with lower respiratory tract infection. The most common bacterial agents of acute pneumonia are Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa. A well-collected sputum specimen, representative of the lower respiratory tract, is necessary for appropriate identifications of pathogens. Unfortunately, expectorated material is frequently contaminated by potentially pathogenic bacteria that colonize the upper respiratory tract (and sometime the lower respiratory tract) without actually causing disease. This contamination reduces the diagnostic specificity of any lower respiratory tract specimen. For this purpose, a Quality (Q) Score is performed on a Gram stained smear to determine the quality of specimen. It involves grading the smear by enumerating the presence of polymorpho neutrophils and squamous epithelial cells. Specimens with Q score of Q1, Q2 & Q3 are considered acceptable for performing culture. A score of Q0 indicates that the specimen is not representative of lower respiratory secretions. Increasing number of epithelial cells accompanied by decreasing numbers of neutrophils indicate salivary contamination. In such situations, a repeat specimen is advised. This is however not true for neutropenic patients. In case in which no clear predominance of a potential pathogen exists on sputum gram stain or culture, the possibility of super infection exists, a more direct method of obtaining lower tract secretion may be necessary. All culture isolates are maintained for a period of 7 days to facilitate additional test, if required. |
| 86 | 1212P | CULTURE – BACTEC BLOOD CULTURE- AEROBIC PAEDIATRIC CULTURE | BACTEC FLUORESCENT METHOD | INOCULATED BACTEC BOTTLE (PEDS PLUS ) | A | Common organisms causing infections are S.aureus, Pseudomonas aeruginosa, S.pneumoniae, Enterobacteriaece ae, Streptococcus & certain Gram negative bacilli. On identification of the organism, antibiotic susceptibilities are performed that aid in selection of appropriate antibiotic for treatment. |
| 87 | 1225 | CULTURE – BACTEC BLOOD CULTURE | BACTEC, VITEK | BLOOD INOCULATED IN AEROBIC/PAEDIATRIC BACTEC BOTTLE | A | To check for the presence of a systemic infection; to detect and identify bacteria in the blood. |
| 88 | 1212 | CULTURE – BACTEC BLOOD CULTURE – AEROBIC | BACTEC FLUORESCENT METHOD | INOCULATED BACTEC BOTTLE (AEROBIC PLUS ) | A | To check for the presence of a systemic infection; to detect and identify bacteria in the blood |
| 89 | 1212AA | CULTURE – BACTEC BLOOD CULTURE (AEROBIC & AEROBIC) | BACTEC, VITEK | AEROBIC BACTEC BOTTLE(TWO) | A | To check for the presence of a systemic infection; to detect and identify bacteria in the blood (AEROBIC & ANAEROBIC) |
| 90 | 1212AN | CULTURE – BACTEC BLOOD CULTURE (AEROBIC & ANAEROBIC) | BACTEC, VITEK | AEROBIC AND ANAEROBIC BACTEC BOTTLE | A | To check for the presence of a systemic infection; to detect and identify bacteria in the blood (AEROBIC & ANAEROBIC). |
| 91 | 1195NP | CULTURE – BACTEC PLUS ANAEROBIC – CULTURE, BODY FLUID | BACTEC FLUORESCENT METHOD | BODY FLUID- STERILE CONTAINER / INOCULATED BACTEC BOTTLE (ANAEROBIC PLUS ) | A | #N/A |
| 92 | 5708 | CULTURE ANAEROBIC-ISOLATION & IDENTIFICATION | CULTURE | ANY SPECIMEN IN STERILE CONTAINER (TRANSPORT MEDIUM MANDATORY) (URINE,STOOL,SWABS & SPUTUM SPECIMEN NOT ACCEPTED) | A | Aerobic Bacteria identification should be performed to determine the susceptibility of the isolate. Results are useful in selecting optimal therapy. |
| 93 | 1221 | CULTURE, AEROBIC – ISOLATION & IDENTIFICATION | BREAKPOINT MIC BY VITEK | PUS, SEMEN IN STERILE CONTAINER | A | #N/A |
| 94 | 1193CS | CULTURE, BLOOD, ISOLATION & IDENTIFICATION + SENSITIVITY | CULTURE + SENSITIVITY BY MIC BREAKPOINT | WB-HEPARIN / WB-SPS (SODIUM POLYANETHANOL SULPHONATE) STERILE CONTAINER | A | #N/A |
| 95 | 1194CS | CULTURE, BODY FLUID, ISOLATION & IDENTIFICATION (CULTURE + SENSITIVITY) | CULTURE + SENSITIVITY BY VITECK | FLUID-STERILE CONTAINER | R | to detect and identify bacteria in the body fluid, When an organism is identified antibiotic sensitivities are performed for the selection of appropriate antibiotics. |
| 96 | 1200CS | CULTURE, CSF-ISOLATION & IDENTIFICATION + SENSITIVITY | CULTURE + SENSITIVITY BY MIC BREAKPOINT | CSF STERILE CONTAINER | A | To diagnose infection affecting the central nervous system with antibiotic susceptibility if organism growth is present. |
| 97 | 1196 | CULTURE, EAR, ISOLATION & IDENTIFICATION | BREAKPOINT MIC BY VITEK | EAR PUS IN STERILE CONTAINER OR SWAB | A | #N/A |
| 98 | 1196M | CULTURE, EAR, ISOLATION & IDENTIFICATION | CULTURE + SENSITIVITY BY MANNUAL METHOD | STOOL-STERILE CONTAINER | R | #N/A |
| 99 | 1211 | CULTURE, EYE- ISOLATION & IDENTIFICATION | BREAKPOINT MIC BY VITEK | EYE PUS IN STERILE CONTAINER OR SWAB | A | #N/A |
| 100 | 1211CS | CULTURE, EYE- ISOLATION & IDENTIFICATION + SENSITIVITY | CULTURE + SENSITIVITY BY MIC BREAKPOINT | CORNEAL SCRAPINGS / CONJUCTIUAL SWAB-STERILE CONTAINER | A | Common organisms causing eye infection are S.aureus, Pseudomonas aeruginosa, S.pneumoniae & Gram negative bacilli On identification of the organism, antibiotic susceptibilities are performed that aid in selection of appropriate antibiotic for treatment. |
| 101 | 1213 | CULTURE, NASOPHARYNGEAL, ISOLATION & IDENTIFICATION +SENSITIVITY | CULTURE | NASAL ASPIRATES IN STERILE CONTAINER | A | Common organisms causing infections are S.aureus and Beta Hemolytic Streptococcus. On identification of theorganism, antibiotic susceptibilities are performed that aid in selection of appropriate antibiotic for treatment. |
| 102 | 1214CS | CULTURE, RESPIRATORY- ISOLATION & IDENTIFICATION + SENSITIVITY | CULTURE + SENSITIVITY BY MIC BREAKPOINT | BAL / BRONCHOSCOPIC BIOPSY / TRACHEAL SECRETION IN STERILE CONTAINER | R | #N/A |
| 103 | 1217CS | CULTURE, SPUTUM – ISOLATION & IDENTIFICATION + SENSITIVITY | CULTURE + SENSITIVITY BY MIC BREAKPOINT | EXPECTORATED SPUTUM -STERILE CONTAINER | R | to detect and identify bacteria in the sputum, When an organism is identified antibiotic sensitivities are performed for the selection of appropriate antibiotics. |
| 104 | 5700CS | CULTURE, STOOL AEROBIC- ISOLATION & IDENTIFICATION (CULTURE + SENSITIVITY) | CULTURE + SENSITIVITY BY VITECK | STOOL-STERILE CONTAINER | R | #N/A |
| 105 | 1219CS | CULTURE, THROAT SWAB – ISOLATION & IDENTIFICATION +SENSITIVITY | CULTURE + SENSITIVITY BY VITECK | SWABS-STERILE CONTAINER | A | to detect and identify bacteria in throat swab, When an organism is identified antibiotic sensitivities are performed for the selection of appropriate antibiotics. |
| 106 | 1285CS | CULTURE, URINE – ISOLATION & IDENTIFICATION (WITH COLONY COUNT) + SENSITIVITY | CULTURE + SENSITIVITY BY VITECK | URINE(EARLY MORNING MID STREAM COLLECTION) STERILE CONTAINER | R (MANDATORY) | Common organisms isolated are E.coli, Klebsiella, S.saprophyticus, S.aureus,Enterococcus, Proteus and Pseudomonas. When an organism is isolated, antibiotic sensitivities are performed to guide antibiotic selection. |
| 107 | 1285CSM | CULTURE, URINE – ISOLATION & IDENTIFICATION (WITH COLONY COUNT) + SENSITIVITY | CULTURE + SENSITIVITY BY MANNUAL METHOD | URINE(EARLY MORNING MID STREAM COLLECTION) STERILE CONTAINER | R (MANDATORY) | #N/A |
| 108 | 1222 | CULTURE, YEAST SCREEN, ISOLATION & IDENTIFICATION | CULTURE & IDENTIFICATION | CSF / BODY FLUID / URINE / SPECIMENS OF BODY FLUIDS,PUS,TISSUE,NAIL CLIPPINGS SKIN SCRAPING,STOOL OR VAGINAL MUCOUS MEMBRANES AND SWABS FROM LESIONS SUSPECTED OF INFECTIONS DUE TO YEAST SHOULD BE COLLECTED ASEPTICALLY IN A STERILE CONTAINER AND TRANSPORTED TO THE LAB AS SOON AS POSSIBLE. IN CASE OF DELAY IN TRANSPORTATION STERILE SALINE MAY BE ADDED. |
R | Antifungal susceptibility testing plays a very important role because of developing antifungal resistance and intrinsic resistance of certain candida species to antifungal agents like Amphotericin B, Fluconazole, Voriconazole, 5Fluorocytosine & Caspofungin. |
| 109 | 1223CS | CULTURE; ENDOTRACHEAL SECRETIONS & SUSCEPTIBILITY | MANUAL & VITEC | ENDOTRACHEAL SECREATION | ENDOTRACHEAL(ET) TUBE | #N/A |
| 110 | 3149 | CYSTATIN C | CHEMILUMINESCENCE | 10 -12 HRS FASTING SERUM + CLINICAL HISTORY + (AGE & GENDER IS MANDATORY) | 2-8°C (7 DAYS); F (> 7 DAYS-90 DAYS, IF F WITHIN 24 HRS. OF COLLECTION) | Cystatin C is used to diagnose renal impairment in early stages. It is a better indicator of renal function than creatinine in the early stages of GFR impairment. |
| 111 | 9436D | CYTOMEGALOVIRUS IgG & IgM ANTIBODIES | ENZYME LINKED IMMUNOSORBENT ASSAY | SERUM | 2-8°C (4 DAYS); -20°C (>4 DAYS) | The CMV test is one of the tests included in a TORCH testing panel. This panel of tests screens for a group of infectious diseases that can cause illness in pregnant women and may cause birth defects in their newborns. TORCH is an acronym for: Toxoplasmosis, Rubella, Cytomegalovirus, and Herpes simplex virus, though it may also screen for other infections. |
| 112 | 9431 | CYTOMEGALOVIRUS IgG ANTIBODIES | ENZYME LINKED IMMUNOSORBENT ASSAY | SERUM | 2-8º C (4DAYS), >4 DAYS- 20 °C | |
| 113 | 2486M | CYTOMEGALOVIRUS IgM ANTIBODIES | ENZYME LINKED IMMUNOSORBENT ASSAY | SERUM | 2-8º C (4DAYS), >4 DAYS- 20 °C | When blood transfusion is needed, certain patients, such as CMV-negative HIV/AIDS patients and CMV-negative heart/lung transplant candidates, should receive blood components that have tested negative for CMV antibodies (so-called CMV seronegative blood products) or products that are leucocytes reduced. |
| 114 | 4200 | D-DIMER (Quantitative) | FLUOROENZYME IMMUNOASSAY | FASTING, CITRATED PLATELET POOR PLASMA* – AT MINUS 20° C*(DOUBLE CENTRIFUGED PLASMA)* | F (TO BE F IMMEDIATELY AT -20°C & TRANSPORTED IN DRY ICE) | This assay is useful in the diagnosis of intravascular coagulation and fibrinolysis / DIC. It also has negative predictive value in excluding the diagnosis of Pulmonary embolism or Deep vein Thrombosis particularly when this assay is combined with clinical information. DDimer levels are increased in DIC / Intravascular coagulation, recent bleeding, hematoma,trauma, surgical operation and thromboembolism. High levels may also be seen in liver disease and malignancy. |
| 115 | 3150 | DEHYDROEPIANDROSTERONE-SULFATE (DHEAS) | CHEMILUMINESCENCE | SERUM (CLINICAL HISTORY REQUIRED ) | 2-8°C (48 HRS), F (> 48 HRS) | This assay is useful in identification of androgen secreting adrenal tumors specially Adrenal carcinomas. It is an adjunct in the diagnosis of Congenital adrenal hyperplasia. It is also useful in the diagnosis of Premature adrenarche. |
| 116 | 1533D | DIRECT LDL | SPECTROPHOTOMETRY | SERUM- 12- 14HRS FASTING | 2-8°C (3 DAYS); F( >3 DAYS) | LDL cholesterol is referred to as the “Bad Cholesterol”. Used to assess the risk of CAD and to decide the treatment. It’s increase is directly related with the risk of CAD. |
| 117 | 1199K | DsDNA (Reflex to end titre for all positive cases) | INDIRECT IMMUNOFLUROSCENT ASSAY. | SERUM | F | dsDNA Antibody is detected in patients with active SLE and approximately 20% of patients with Mixed connective tissue disease. |
| 118 | 1568UHD | ELECTROLYTES (NA/K/CL), 24HRS URINE | IMT | 24HR URINE/RANDOM (URINE CONTAINER) | Na/K : 20-25 °C 45 DAYS (CL 7 DAYS) | To detect a problem with your body’s electrolyte balance |
| 119 | 1568HD | ELECTROLYTES (NA/K/CL), SERUM | IMT | SERUM | RED /GEL 20-25 °C – Na: 2 WEEK; K : 1 WEEK; CL 7 DAYS | Sodium levels are Increased in dehydration, cushing’s syndrome, aldosteronism & decreased in Addison’s disease, hypopituitarism,liver disease. Hypokalemia (low K) is common in vomiting, diarrhea, alcoholism, folic acid deficiency and primary aldosteronism. Hyperkalemia may be seen in end-stage renal failure, hemolysis, trauma, Addison’s disease, metabolic acidosis, acute starvation, dehydration, and with rapid K infusion.Chloride is increased in dehydration, renal tubular acidosis (hyperchloremia metabolic acidosis), acute renal failure, metabolic acidosis associated with prolonged diarrhea and loss of sodium bicarbonate, diabetes insipidus, adrenocortical hyperfuction, salicylate intoxication and with excessive infusion of isotonic saline or extremely high dietary intake of salt.Chloride is decreased in overhydration, chronic respiratory acidosis, salt-losing nephritis, metabolic alkalosis, congestive heart failure, Addisonian crisis, certain types of metabolic acidosis, persistent gastric secretion and prolonged vomiting, |
| 120 | 1236K | ENA PROFILE | Enzyme Linked Immnunosorbent assay | SERUM | 2-8°C (14 days); -20°C (>14 days) | An extractable nuclear antigen (ENA) panel detects the presence of autoantibodies in the blood that react with proteins in the cell nucleus. These proteins are known as “extractable” because they can be removed from cell nuclei using saline and represent six main proteins (Ro, La, Sm, RNP, Scl-70 and Jo1). |
| 121 | 1569B | ERYTHROSITE SEDIMENTATION RATE (ESR), BLOOD | MODIFIED WESTERGREN | CITRATE WHOLE BLOOD | BLACK TOP | |
| 122 | 3155 | ESTRADIOL | CHEMILUMINESCENCE | SERUM (CLINICAL HISTORY REQUIRED) | 2-8°C (48 hrs); F (>48 hrs) | Autoantibodies are produced when a person’s immune system mistakenly targets and attacks the body’s own tissues. This attack can cause inflammation, tissue damage, and other signs and symptoms that are associated with an autoimmune disorder. |
| 123 | 1949 | FACTOR IX ACTIVITY | CLOT BASED | FASTING, CITRATED PLATELET POOR PLASMA* – AT MINUS 20° C(DOUBLE CENTRIFUGED PLASMA)* + CLINICAL HISTORY | F (TO BE F IMMEDIATELY AT -20°C & TRANSPORTED IN DRY ICE) | |
| 124 | 5019 | FACTOR V ACTIVITY (CITRATED PLASMA) | Test done on Fully Automated Coagulometer (Clotting) | Platelet Poor Citrated plasma | FROZEN | Certain autoimmune disorders are characteristically associated with the presence of one or more anti-ENA antibodies. Autoantibody association can aid in the diagnosis of an autoimmune disorder and help distinguish between other autoimmune disorders. |
| 125 | 5018 | FACTOR VII ACTIVITY PROCONVERTIN | Photo Optical clot Detection | Platelet Poor Citrated plasma | F | |
| 126 | 1947 | FACTOR VIII ACTIVITY | CLOT BASED | FASTING, CITRATED PLATELET POOR PLASMA* – AT MINUS 20° C(DOUBLE CENTRIFUGED PLASMA)* + CLINICAL HISTORY | F (TO BE F IMMEDIATELY AT -20°C & TRANSPORTED IN DRY ICE) | The ENA panel typically consists of a group of 4 or 6 autoantibody tests. The number of tests performed will depend on the laboratory and the needs of the healthcare practitioners and patients it serves. Individual ENA panel tests can also be ordered separately. |
| 127 | 3170 | FERRITIN | CHEMILUMINESCENCE | SERUM (AGE+GENDER+ CLINICAL HISTORY REQUIRED) | 2-8°C (48 HRS); F (>48 HRS) | Ferritin levels reflect iron stoes in normal individuals. A low serum ferritin level is an indicator of iron depletion. This assay is clinically useful in distinguishing between Iron deficiency anemia (low level) and anemia of chronic disease (normal or high level). It is also useful to assess iron overload conditions like Hemochromatosis. Ferritin is also an acute phase reactant. |
| 128 | 1426 | FIBRINOGEN LEVEL | CLOT BASED ( CLAUSS ) | FASTING, CITRATED PLATELET POOR PLASMA* – AT MINUS 20° C *(DOUBLE CENTRIFUGED PLASMA)* | F (TO BE F IMMEDIATELY AT -20°C & TRANSPORTED IN DRY ICE) | In Dysfibrinogenemia , clotting activity may be lower than indicated by the fibrinogen concentration, becausefibrinogen is not fully functional. The clotting assay is also useful in determining the availability of substrate for clot formation. |
| 129 | 1518 | FINE NEEDLE ASPIRATION CYTOLOGY (FNAC), PROCEDURE (FOR SRL KABUL WALK-IN PATIENTS ONLY) | CYTOLOGY PROCEDURE – FINE NEEDLE ASP. |
FIXED UNSTAINED SMEARS + SITE OF COLLECTION & clinical history | A | (FOR SRL MUMBAI WALK-IN PATIENTS ONLY) |
| 130 | 1515A | FINE NEEDLE ASPIRATION, CYTOLOGY (FNAC), NON-GYNAEC CYTOLOGY | CYTOLOGY | FIXED UNSTAINED SMEARS.(Clinical history required) | A – SMEAR | Aspiration cytology from a variety of organ sites is useful in the determination of pathologic states particularly neoplasms & inflammatory conditions. Most common sites examined include breast, liver, kidney, lung, prostate, pancreas, retroperitoneum, salivary glands, thyroid & lymph nodes. |
| 131 | 5197 | FLUID, ROUTINE | MANUAL/ CYTOSPIN | FLUID | STERILE CONTAINER | Laboratory testing can be performed on many types of fluids from the body other than blood. Often, these fluids are tested instead of blood because they can give more direct answers to what may be going on in a particular part of the body. |
| 132 | 3522 | FOLIC ACID (FOLATE) | CHEMILUMINESCENCE | SERUM | 2-8°C (48 hrs); F (>48 hrs) | Folates function as coenzymes in many metabolic pathways. Testing is useful in detecting folate deficiency and to monitor folate therapy. Folate deficiency. is a cause of Megaloblastic and Macrocytic anemias. |
| 133 | 3174 | FOLLICLE STIMULATING HORMONE (FSH) | CHEMILUMINESCENCE | SERUM ( AGE+GENDER+LMP+CLINICAL HISTORY REQUIRED )DRAW SAMPLE BETWEEN 8 AM TO 10AM, 3-4 HRS AFTER THE PATIENT HAS AWAKENED. | 2-8°C (48 HRS); F (>48 HRS) | This assay is useful as an adjunct in the evaluation of menstrual irregularities. It also evaluates patients with suspected hypogonadism, predicts ovulation, evaluates infertility and helps in diagnosing pituitary disorders. |
| 134 | 3228 | FREE THYROXINE , FT4 | CHEMILUMINESCENCE | SERUM | 2-8°C (48 HRS); F (>48 HRS) | Free T3 is a supplemental test to TSH and free T4 for confirmation of thyroid status. This assay also helps to monitor thyroid hormone replacement therapy. Elevated levels are associated with Thyrotoxicosis or excess thyroid hormone replacement. |
| 135 | 3234 | FREE TRIIODOTHYRONINE, FT3 | CHEMILUMINESCENCE | SERUM | 2-8°C (48 HRS); F (>48 HRS) | Free T4 is the metabolically active fraction of thyroxine. FT4 along with TSH gives an accurate picture of thyroid status in patients with abnormal thyroid binding globulin (TBG) like in pregnancy and individuals on treatment with estrogens, androgens, phenytoin or salicylates. This assay is useful for diagnosing both Hypo / Hyperthyroidism. |
| 136 | 5323 | FUNGAL STAIN | STAIN / MICROSCOPY | SPUTUM / CSF / FLUID / URINE / ASPIRATE / TISSUE BIOPSY- STERILE CONTAINER | A/R | Fungal infections are more common in immunocompromi sed patients. Direct examination provides an immediate early presumptive diagnosis and initiation of antifungal therapy. |
| 137 | 1126 | G6-PD (GLUCOSE-6-PHOSPATE DEHYDROGENASE), (QUALITATIVE) | DYE DECOLORIZATION | WB-EDTA | A | G6PD deficiency is a sex linked disorder affecting males whereas females are the carriers. More than 300 variants of G6PD are known, hence deficiency can range from asymptomatic to acute hemolytic episodes. These episodes can be triggered by drugs, ingestion of fava beans, viral and bacterial infections. |
| 138 | 4166 | GALL BLADDER STONE ANALYSIS | BIOCHEMICAL | WHOLE GALL BLADDER STONE.Please provide the clinical details. | A/R | FTIR spectroscopy is used for stone analysis as the precise wavelength scale improves test accuracy. The routine, easy and rapid measurements give unambiguous information about the stone composition.Thera py for the stone disease is usually based on the analysis of calculi, permitting a proper management of the disease and prevention of its recurrence. |
| 139 | 1294H | GAMMA GLUTAMYL TRANSFERASE (GGT), SERUM | SPECTROPHOTOMETRY | SERUM | RED | Serum gamma-glutamyl transferase (GGT) has been widely used as an index of liver dysfunction. Elevated serum GGT activity can be found in diseases of the liver, biliary system, and pancreas .Conditions that increase serum GGT are obstructive liver disease, high alcohol consumption, and use of enzyme-inducing drugs etc. |
| 140 | 1127BS | GESTATIONAL GLUCOSE TOLERANCE – 3 | SPECTROPHOTOMETRY | SERUM | GREY | Most women are screened for gestational diabetes between 24 and 28 weeks of pregnancy. Sometimes a test for diabetes is done earlier in your pregnancy if you are suspected of having pre-existing diabetes or have risk factors for gestational diabetes |
| 141 | 1302GCT | GLUCOSE CHALLENGE TEST | SPECTROPHOTOMETRY | PLASMA FLOURIDE | GREY | The glucose challenge test measures your body’s response to sugar (glucose). The glucose challenge test is done during pregnancy to screen for gestational diabetes — diabetes that develops during pregnancy. |
| 142 | 1302R | GLUCOSE RANDOM, PLASMA | SPECTROPHOTOMETRY | SERUM | GREY | To determine if your blood glucose level is within a healthy range; |
| 143 | 1683 | GLUCOSE, CSF /FLUID | SPECTROPHOTOMETRY | CSF/SERUM | S. CONTAINER + GREY. | |
| 144 | 1302H | GLUCOSE, FASTING, PLASMA | SPECTROPHOTOMETRY | SERUM | GREY | To determine if your blood glucose level is within a healthy range; to screen for and diagnose diabetes and prediabetes and to monitor for high blood glucose (hyperglycemia) or low blood glucose (hypoglycemia); |
| 145 | 1302 | GLUCOSE, POST-PRANDIAL, PLASMA | SPECTROPHOTOMETRY | SERUM | GREY | To determine if your blood glucose level is within a healthy range; to screen for and diagnose diabetes and prediabetes |
| 146 | 1302UH | GLUCOSE, URINE | SPECTROPHOTOMETRY | 24HR URINE/RANDOM | URINE CONTAINER | Limited usefulness in the screening or management of diabetes mellitus |
| 147 | 3180 | GLYCOSYLATED HEMOGLOBIN (HBA1C), EDTA WHOLE BLOOD | HPLC | EDTA WHOLE BLOOD | EDTA | GHb has been firmly established as an index of long term blood glucose concentrations and as a measure of the risk for the development of complications in patients with diabetes mellitus. The absolute risk of retinopathy and nephropathy are directly proportional to the mean of HbA1C. |
| 148 | 2438B | GONOCOCCAL SMEAR | MICROSCOPY | FROM RESPECTIVE SITE | STERILE CONTAINER | To detect and identify Gonococci |
| 149 | 2438 | GRAM STAIN | MICROSCOPY | SPUTUM ,PUS ,FLUID | STERILE CONTAINER | To detect the presence and identify the general type of bacteria or sometimes fungi (microbes) in a sample taken from the site of a suspected infection; to generally classify bacteria grown in culture so that further identification tests can be performed and appropriate treatment given |
| 150 | 3182 | GROWTH HORMONE (GH) | CHEMILUMINESCENCE | SERUM, PATIENT MUST BE FASTING AND AT COMPLETE REST 30 MINUTES BEFORE BLOOD COLLECTION | FROZEN: UP TO 2 Months | This assay is useful for the diagnosis of Acromegaly / Gigantism and assessment of treatment efficacy.It is used to diagnose Growth hormone deficiency specially in children with short stature. This test should be used in conjunction with stimulation and suppression tests for definite results. |
| 151 | 5101 | HB,TLC,DLC (HEMOGLOBIN, TOTAL LEUKOCYTE COUNT, DIFFERENTIAL COUNT) | 5 PART AUTOANALYSER | EDTA WHOLE BLOOD , SMEARS | EDTA | This test is done to determine your general health status; to screen for, diagnose, or monitor any one of a variety of diseases and conditions that affect blood cells, such as anemia, infection, inflammation, bleeding disorder or cancer |
| 152 | 5102 | HB,TLC,DLC,ESR (HEMOGLOBIN, TOTAL LEUKOCYTE COUNT, DIFFERENTIAL COUNT, ERYTHROCYTE SEDIMENTATION RATE) | 5 PART AUTOANALYSER | EDTA WHOLE BLOOD , CITRATE WHOLE BLOOD | EDTA , BLACK TOP | This test is done to determine your general health status; to screen for, diagnose, or monitor any one of a variety of diseases and conditions that affect blood cells, such as anemia, infection, inflammation, bleeding disorder or cancer. ESR is done to detect the presence of inflammation caused by one or more conditions such as infections, tumors or autoimmune diseases; to help diagnose and monitor specific conditions such as temporal arteritis, systemic vasculitis, polymyalgia rheumatica, or rheumatoid arthritis |
| 153 | 9972k | HCV VIRAL LOAD BY REAL TIME PCR | REAL TIME PCR | PLASMA-EDTA | F | to detect HCV viral load |
| 154 | 1124HD | HDL CHOLESTEROL, SERUM | SPECTROPHOTOMETRY | SERUM | RED /GEL | High-density lipoprotein (HDL) cholesterol. This is sometimes called the “good” cholesterol because it helps carry away LDL cholesterol, thus keeping arteries open and blood flowing more freely.HDL cholesterol is inversely related to the risk for cardiovascular disease. It increases following regular exercise, moderate alcohol consumption and with oral estrogen therapy. Decreased levels are associated with obesity, stress, cigarette smoking and diabetes mellitus. |
| 155 | 7737B | HELICOBACTER PYLORI ANTIBODIES,(H PYLORI, BLOOD) | ENZYME IMMUNOASSAY | SERUM | RED/EDTA/HEPARIN. 2-8°C 7 DAY | rapid, quantitative immunoassay to detect IgG/ IgA/IgM class antibodies against HELICOBACTER PYLORI |
| 156 | 7737 | HELICOBACTER PYLORI ANTIGEN (H. PYLORI), FECAL | ENZYME IMMUNOASSAY | STOOL-STERILE CONTAINER | STERILE CONTAINER | rapid, quantitative immunoassay to detect IgG/ IgA/IgM class antibodies against HELICOBACTER PYLORI |
| 157 | 5112 | HEMOGLOBIN & HEMATOCRIT (HB,HCT), EDTA WHOLE BLOOD | 5 PART AUTOANALYSER | EDTA WHOLE BLOOD | EDTA: 2-8 °C 24 HR | Low hemoglobin/hematocrit level may be due to various types of red cell disorders leading to anemia; loss of blood (e.g. bleeding from digestive tract or bladder, heavy menstrual periods); decreased red cell production (e.g. Chronic kidney disease, chronic inflammatory conditions, red cell aplasia, leukemias, drug toxicity, radiation therapy); infection and bone marrow failure. High hemoglobin/hematocrit level is most often due to hypoxia, present over a long period of time. Certain congenital defects of the heart, failure of the right side of the heart (cor pulmonale), severe COPD, pulmonary fibrosis and other severe lung disorders are also associated with high hemoglobin and hematocrit. Other reasons includes polycythemia vera and dehydration. |
| 158 | 5112DR | HEMOGLOBIN (HB), EDTA WHOLE BLOOD | CYANMETHEMOGLOBIN | EDTA WHOLE BLOOD | EDTA: 2-8 °C 24 HR | Low hemoglobin/hematocrit level may be due to various types of red cell disorders leading to anemia; loss of blood (e.g. bleeding from digestive tract or bladder, heavy menstrual periods); decreased red cell production (e.g. Chronic kidney disease, chronic inflammatory conditions, red cell aplasia, leukemias, drug toxicity, radiation therapy); infection and bone marrow failure. High hemoglobin/hematocrit level is most often due to hypoxia, present over a long period of time. Certain congenital defects of the heart, failure of the right side of the heart (cor pulmonale), severe COPD, pulmonary fibrosis and other severe lung disorders are also associated with high hemoglobin and hematocrit. Other reasons includes polycythemia vera and dehydration. |
| 159 | 3834K | HEMOGLOBIN VARIANT ANALYSIS (HB ELECTROPHORESIS) | GEL ELECTROPHORESIS | EDTA WHOLE BLOOD | EDTA ,PLAIN | This assay is useful in the diagnosis of Beta Thalassemia. It quantitates the percent of fetal hemoglobin and assists in the diagnosis of disorders with elevated levels of HbF. |
| 160 | 2460R | HEPATITIS A VIRUS IGG & IGM ANTIBODIES, RAPID | RAPID | SERUM | 2-8°C (3 DAYS); -20°C (> 14 DAYS) | rapid test to detect IgG & IgM Antibodies to HEPATITIS A (HAV) |
| 161 | 2452S | HEPATITIS B CORE ANTIBODY TOTAL -SERUM (RAPID) | RAPID | SERUM | RED/GEL . 2-8°C (7DAYS) ,>7 DAYS -20°C | This assay is useful for diagnosis of recent or past Hepatitis B infection. It helps to determine occult HBV infection in healthy HBV carriers with negative results for HBsAg, Anti HBs, Anti HBc IgM, HBeAg and Anti HBe. This assay is not useful for differentiating between acute, chronic and resolved HBV infection. |
| 162 | 2452 | HEPATITIS B CORE TOTAL ANTIBODIES | CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY (CMIA) | SERUM | AMBIENT:3 DAYS, 2-8°C (7DAYS) ,>7 DAYS -20°C | This assay is useful for diagnosis of recent or past Hepatitis B infection. It helps to determine occult HBV infection in healthy HBV carriers with negative results for HBsAg, Anti HBs, Anti HBc IgM, HBeAg and Anti HBe. This assay is not useful for differentiating between acute, chronic and resolved HBV infection. |
| 163 | 2453QN | HEPATITIS B SURFACE ANTIBODIES (HBsAb), TOTAL WITH TITRE | CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY (CMIA) | SERUM | 2-8°C 14 DAYS) ,>14 DAYS -20°C | This assay is useful for identifying previous exposure to HBV and determining adequate immunity from Hepatitis B vaccination. |
| 164 | 2453 | HEPATITIS B SURFACE ANTIBODY-SERUM (RAPID) | RAPID | SERUM | RED/GEL . 2-8°C (7DAYS) ,>7 DAYS -20°C | This assay is useful for identifying previous exposure to HBV and determining adequate immunity from Hepatitis B vaccination. |
| 165 | 2470 | HEPATITIS B SURFACE ANTIGEN (HBSAG QUALITATIVE), SERUM | CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY (CMIA) /MEIA | SERUM | RED/GEL . 2-8°C (7DAYS) ,>7 DAYS -20°C | HbsAg is the first serologic marker appearing in the serum 6-16 weeks following hepatitis B viral infection. In typical HBV infection, HBsAg will be detected 2-4 weeks before the liver enzyme levels (ALT) become abnormal and 3-5 weeks before patient develops jaundice.In acute cases HbsAg usually disappears 1-2 months after the onset of symptoms.Persistence of HbsAg for more than 6 months indicates development of either a chronic carrier state or chronic liver disease.The presence of HbsAg is frequently associated with infectivity. HbsAg when accompanied by Hepatitis Be antigen and/or hepatitis B viral DNA almost always indicates infectivity. |
| 166 | 2470R | HEPATITIS B SURFACE ANTIGEN (HBsAG) Reflux to CMIA 2470 | Immunochromatogrphy | SERUM | A | This test detects the presence of viral surface antigen (HbsAg) in serum sample and is indicative of an active HBV infection, either acute or chronic. |
| 167 | 8141k | HEPATITIS B VIRUS DNA DETECTOR, ( HBV ) QUALITATIVE | REAL TIME PCR | SERUM OR PLASMA – EDTA | F | HBV PCR has immense diagnostic utility in patients who have inconclusive serology results especially in cases of chronic hepatitis B infection and in HBV carriers. |
| 168 | 6013 | HEPATITIS B VIRUS PROFILE (QUALITATIVE) | IMMUNOCHROMATOGRAPHY ASSAY | SERUM | RED/GEL . 2-8°C (7DAYS) ,>7 DAYS -20°C | Hepatitis B is an infection of the liver caused by the hepatitis B virus (HBV). Hepatitis B blood tests detect viral proteins (antigens), the antibodies that are produced in response to an infection, or detect or evaluate the genetic material (DNA) of the virus. The pattern of test results can identify a person who has a current active infection, was exposed to HBV in the past, or has immunity as a result of vaccination. |
| 169 | 2446 | HEPATITIS C ANTIBODIES | CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY (CMIA) | SERUM | 2-8°C (7 DAYS) ,>7DAYS -20°C | HCV is the most common cause of Post transfusion hepatitis. HCV antibodies usually appear in the late convalescent stage >6 months after onset of infection. This assay is the screening test for resolved or chronic HCV. |
| 170 | 2446R | HEPATITIS C VIRUS ABS (ANTI HCV), RAPID, SERUM Reflux to CMIA 2446) | RAPID SANDWICH IMMUNOASSAY | SERUM | RED/GEL, 2-8°C (3 DAYS) ,>3 MONTH -20°C | rapid test to detect HEPATITIS C ANTIBODIES |
| 171 | 9451 | HERPES SIMPLEX VIRUS IgG TYPE 1 ANTIBODIES | Enzyme Linked Immnunosorbent assay | SERUM | 2-8º C (4 DAYS), >4 DAYS- 20 °C | HSV1 is closely associated with orolabial infections and HSV encephalitis. HSV1 serum testing is particularly useful for the followup of pregnant women, who were not previously exposed to HSV1 and consequently are not protected against the virus. The presence of HSV1 IgG antibody in serum is an indication of previous exposure. A significant increase in HSV IgG is an indication of reactivation, current or recentinfection. |
| 172 | 9461 | HERPES SIMPLEX VIRUS IgG TYPE 2 ANTIBODIES | Enzyme Linked Immnunosorbent assay | SERUM | 2-8º C (4 DAYS), >4 DAYS- 20 °C | HSV2 is the primary cause of initial and recurrent genital herpes and neonatal HSV. The test is particularly useful for the followup of pregnant women, who were not previously exposed to HSV2 and consequently are not protected against the virus. |
| 173 | 9456 | HERPES SIMPLEX VIRUS IgM TYPE 1 ANTIBODIES | Enzyme Linked Immnunosorbent assay | SERUM | 2-8º C (4 DAYS), >4 DAYS- 20 °C | HSV1 is closely associated with orolabial infections and HSV encephalitis. HSV1 serum testing is particularly useful for the followup of pregnant women, who were not previously exposed to HSV1 and consequently are not protected against the virus.The presence of HSV1 IgM antibody in serum is an indicator of active infection. |
| 174 | 9466 | HERPES SIMPLEX VIRUS IgM TYPE 2 ANTIBODIES | Enzyme Linked Immnunosorbent assay | SERUM | 2-8º C (4 DAYS), >4 DAYS- 20 °C | HSV2 is the primary cause of initial and recurrent genital herpes and neonatal HSV. The test is particularly useful for the followup of pregnant women, who were not previously exposed to HSV2 and consequently are not protected against the virus. |
| 175 | 1537D | HIGH SENSITIVE C-REACTIVE PROTEIN (hsCRP) | NEPHELOMETRY | 10 -12 HRS FASTING SERUM + CLINICAL HISTORY + (AGE & GENDER IS MANDATORY) | 2-8°C (8 DAYS); F (> 8 DAYS- 8 MONTHS, IF F WITHIN 24 HRS. OF COLLECTION) | C Reactive Protein (CRP) is the most sensitive acute phase reactant for inflammation. Mild elevation of CRP has emerged as a valuable marker of cardiovascular risk including first & recurrent Coronary stroke, Myocardial infarction, Angina and Congestive heart failure. hsCRP is a sensitive predictor of increased cardiovascular risk in both men and women. This assay is used for assessment of risk of developing Myocardial infarction in patients presenting with Acute coronary syndrome. It also assesses risk of developing Cardiovascular disease or ischemic event in individuals who do not manifest disease at present. |
| 176 | 7534 | HIGH SENSITIVE TROPONIN I (QUANTITATIVE) | CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY (CMIA) | SERUM ( Age+Gender mandatory) | 2-8°C (24 HRS); F (1 Month) | Troponin I is a cardiac marker elevated only in patients suffering from acute Myocardial Infarction. Patients with renal disease or acute muscle injury show normal levels.High sensitivity assays can detect elevated levels of Troponin I (above the 99th percentile of an apparently healthy reference population) within 3 hours after the onset of chest pain. |
| 177 | 9916R | HIV 1 & 2 ANTIBODIES (REFLUX to CMIA 9916F) | Immunochromatogrphy | SERUM | A | The current technique used to detect antibodies to HIV 1&2 is a screening test. |
| 178 | 9916F | HIV AG/AB COMBO (QUALITATIVE), SERUM | CHEMILUMINESCENT MICROPARTICLE IMMUNOASSAY (CMIA) /MEIA | SERUM | RED/GEL . 2-8°C (7DAYS) ,>7 DAYS -20°C | HIV-1&2 ANTIBODIES, SERUM Acquired immunodeficiency syndrome (AIDS) is caused by 2 types of human immunodeficiency viruses, collectively designated HIV. HIV is transmitted by sexual contact, exposure to blood or blood products, and prenatal infection of a fetus or perinatal infection of a newborn. Phylogenetic analysis classifies HIV-1 into groups M (major), N (non-M, non-O), and O (outlier).HIV-2 is similar to HIV-1 in its structural morphology, genomic organization, cell tropism, in vitro cytopathogenicity, transmission routes, and ability to cause AIDS. However, HIV-2 is less pathogenic than HIV-1.HIV-2 infections have a longer latency period with slower progression to disease, lower viral titers, and lower rates of vertical and horizontal transmission. HIV-2 is endemic to West Africa but HIV-2 infections, at a low frequency compared to HIV-1, have been identified in the USA, Europe, Asia, and other regions of Africa. India predominantly has HIV-1M subtype C. Test Utility; The test is used as an aid in the diagnosis of HIV-1/HIV-2 infection . If HIV reactive result is obtained, confirmation of HIV antibody status is done using 2 more antibody tests ( as per NACO guidelines-Strategy III algorithm) . If indicated HIV serostatus may be confirmed by repeating antibody test on fresh specimen or HIV-1 Western Blot (Immunoblot) Assay (SRL test code #3012). Limitations: – Antibody tests may give false negative during the window period, an interval of 3 weeks to 6 months between the time of HIV infection and the production of measurable antibodies to HIV seroconversion. Most people develop detectable antibodies approximately 30 days after infection, although some seroconvert later. The vast majority of people (97%) have detectable antibodies by three months after HIV infection; a 6-month window is extremely rare with modern antibody testing. – Early antiretroviral therapy during the window period may alter antibody responses. This does not apply to individuals undergoing treatment with post-exposure prophylaxis (PEP). – Antibody tests may yield false negative results in patients with X-linked agammaglobulinemia. – A positive HIV result in an infant <18 months of age may not reflect the infant””””””””””””””””””””””””””””””””s HIV infection status.HIV antibodies persist in the sera of infants upto 18 months of age, due to transplacentally acquired maternal antibodies. HIV PCR testing is recommended in this age group for diagnosis. |
| 179 | 9974K | HIV-1 VIRAL LOAD BY REAL TIME PCR | PCR | PLASMA- EDTA | F | This test is intended for use as an aid in the management of HIV 1 infected patients and is not intended for use in the initial diagnosis or confirmation of HIV 1 infection. This test is used to assess patient prognosis and monitor the effect of antiretroviral therapy. |
| 180 | 3344 | HOMOCYSTEINE | CHEMILUMINESCENCE | SERUM / PLASMA-EDTA – CENTRFUGE SAMPLES AND REMOVE SERUM OR PLASMA FROM RED BLOOD CELLS AS SOON AS POSSIBLE TO ENSURE ACCURATE MEASUREMENT. | 2-8°C (48 HRS); F (>48 HRS) | An elevated concentration of Homocysteine is an independent risk factor for cardiovascular disease. |
| 181 | 1282GNID | IDENTIFICATION – GRAM NEGATIVE ORGANISM | IDENTIFICATION BY VITEK | PURE FRESHLY SUB-CULTURED ISOLATE | R | To detect and identify gram negative organism |
| 182 | 1281GPID | IDENTIFICATION – GRAM POSITIVE ORGANISM | IDENTIFICATION BY VITEK | PURE FRESHLY SUB-CULTURED ISOLATE | R | To detect and identify gram positive organism |
| 183 | 1245E | IgE, TOTAL | CHEMILUMINESCENCE | SERUM + CLINICAL HISTORY (Age is Mandatory for reporting) | 2-8°C (48 hrs); F (>48 hrs) | Atopic allergy implies a familial tendency to manifest conditions like Asthma, Rhinitis, Urticaria and Eczematous dermatitis either alone or in association with the presence of IgE. Some individuals without atopy may develop hypersensitivity reactions due to presence of specific IgE. |
| 184 | 3192 | INSULIN, Serum (Fasting) | CHEMILUMINESCENCE | FASTING SERUM ( ORAL HYPOGLYCEMIC AGENTS/ SUREPTITIOUS INSULIN CAUSES ELEVATED INSULIN VALUE, FREEZE THE SAMPLE IMMEDIATELY AFTER SEPARATION) | 2-8°C (24 HRS); F (>24 HRS) | Insulin is produced by beta cells of the pancreas. It leads to Type 1 (IDDM) diabetes caused by Insulin deficiency & Type 2 (NIDDM) diabetes caused by insulin resistance. This assay is useful in the management of Diabetes. It is also used for diagnosing Insulinoma when used in conjunction with Proinsulin and Cpeptide measurement. |
| 185 | 3192A | INSULIN, Serum (POST-PRANDIAL) | CHEMILUMINESCENCE | PP SERUM ( ORAL HYPOGLYCEMIC AGENTS/ SURREPTITIOUS INSULIN CAUSES ELEVATED INSULIN VALUE, FREEZE THE SAMPLE IMMEDIATELY AFTER SEPARATION) | 2-8°C (24 HRS); F (>24 HRS) | Insulin is produced by beta cells of the pancreas. It leads to Type 1 (IDDM) diabetes caused by Insulin deficiency & Type 2 (NIDDM) diabetes caused by insulin resistance. This assay is useful in the management of Diabetes. It is also used for diagnosing Insulinoma when used in conjunction with Proinsulin and Cpeptide measurement. |
| 186 | 3532D | IRON, SERUM | SPECTROPHOTOMETRY | SERUM | RED /GEL | Along with other iron tests, to determine your blood iron level; along with other tests, to help diagnose iron-deficiency anemia or iron overload |
| 187 | 4161 | KIDNEY STONE ANALYSIS | CHEMICAL ANALYSIS | KIDNEY STONE SAMPLE ( WITH OR WITHOUT D/W OR NORMAL SALINE) | R | FTIR spectroscopy is used for stone analysis as the precise wavelength scale improves test accuracy. The routine, easy and rapid measurements give unambiguous information about the stone composition.Thera py for the stone disease is usually based on the analysis of calculi, permitting a proper management of the disease and prevention of its recurrence. |
| 188 | 1398 | L E CELL | MICROSCOPY | WB-HEPARIN / EDTA | A | A positive LE cell test is suggestive of Systemic Lupus Erythematosus (SLE). However, the test is positive in only 75% of patients with SLE. Positive reactions have been reported in Lupoid Hepatitis, and in drug reactions. Positive tests can also be seen in 3.6% of patients with rheumatoid arthritis, especially when the disease is severe and highly active. |
| 189 | 1009H | LACTATE DEHYDROGENASE, SERUM (LDH) | SPECTROPHOTOMETRY | SERUM | RED /GEL | LDH levels help to diagnose lung disease, lymphoma, anemia, and liver disease. They also help determine how well chemotherapy is working .A higher-than-normal level may indicate:Blood flow deficiency (ischemia), Heart attack, Hemolytic anemia, Infectious mononucleosis, Liver disease (for example, hepatitis),Low blood pressure,Muscle injury, muscular dystrophy, New abnormal tissue formation usually cancer, Pancreatitis and Stroke. |
| 190 | 3198 | LH (LUTEINIZING HORMONE) | CHEMILUMINESCENCE | SERUM (AGE + GENDER + CLINICAL HISTORY REQUIRED) | 2-8°C (48 HRS ); F (>48 HRS) | This assay is used for evaluating patients with suspected Hypogonadism, predicting ovulation, evaluating Infertility and diagnosing Pituitary disorders. This assay is also an adjunct in the evaluation of menstrual irregularities. In both males & females Primary hypogonadism results in elevated levels of basal LH & FSH. LH is decreased in Primary ovarian hyperfunction in females & Primary hypergonadism in males. |
| 191 | 3369D | LIPASE | SPECTROPHOTOMETRY | SERUM 10- 12 HRS FASTING (AGE & GENDER IS MANDATORY) | 2-8°C (7 DAYS),, F (>7 DAYS) | Lipase is an enzyme produced almost exclusively from pancreatic acinar cells. Pancreatic injury increases serum lipase levels. In Pancreatitis, it rises almost at the same time as amylase (48 hrs) but the elevation lasts much longer (710 days) as compared to amylase. |
| 192 | 4866UH | MAGNESIUM, 24HRS URINE | SPECTROPHOTOMETRY | 24HR URINE/RANDOM | URINE CONTAINER | To measure hypo or hyper magnesium level in urine |
| 193 | 4866H | MAGNESIUM, SERUM | SPECTROPHOTOMETRY | SERUM | RED /GEL | To measure hypo or hyper magnesium level in serum |
| 194 | 1395 | MALARIA ANTIGEN (P. FALCIPARUM/P.VIVAX) DETECTION | IMMUNOCHROMATOGRAPHY | WB-EDTA / HEPARIN | 2-8°C (3 days),>3 days -20 °C | Malaria is a protozoan parasitic infection, prevalent in subtropical and tropical parts of the world. This test is not to be used in lieu of conventional smear diagnosis. Occasionally, test may show negativity even in presence of smear positivity. |
| 195 | 1397 | MALARIAL PARASITE (M.P), EDTA WHOLE BLOOD/SMEAR | MICROSCOPY | EDTA WHOLE BLOOD | EDTA | To detect malaria parasite in peripheral blood smear. Malaria parasite may not be detected on peripheral blood smear if infestation rate is very low. |
| 196 | 3441U | MICRO ALBUMINURIA (SPOT URINE) | SPECTROPHOTOMETRY | 24HR URINE/RANDOM | URINE CONTAINER | test to detect very small levels of a blood protein (albumin) in your urine. A microalbumin test is used to detect early signs of kidney damage in people who are at risk of developing kidney disease. |
| 197 | RD1324K | MTB PLUS (XPERT MTB / RIF) | REAL TIME PCR | SPUTUM/ BAL/ URINE/ FNAC/ MENSTURAL BLOOD / ASCITIC / PLEURAL / CSF FLUIDS/ TISSUE IN STERILE NORMAL SALINE / BONE MARROW-EDTA / PARAFFIN BLOCK BLOOD SPECIMEN (SWABS AND ACCEPTED) | A | This is a sensitive PCR assay for the detection of Mycobacterium tuberculosis complex and Non Tuberculous Mycobacteria (NTM). |
| 198 | 9716 | MUMPS IgG ANTIBODIES | Enzyme Linked Immnunosorbent assay | SERUM | 2-8°C (9DAYS); -20 TO -70°C (>9 DAYS) | This assay is used for the laboratory diagnosis of Mumps virus infection. Absence of detectable IgG antibodies suggests lack of specific immune response to immunization and no previous exposure to the virus. |
| 199 | 9721 | MUMPS IgM ANTIBODIES | Enzyme Linked Immnunosorbent assay | SERUM | 2-8°C (9DAYS); -20 TO -70°C (>9 DAYS) | This assay is used for the laboratory diagnosis of Mumps virus infection. Detection of IgM antibodies supports a clinical diagnosis of recent / acute phase infection with the virus. |
| 200 | 3612 | MYOGLOBIN | FLUOROENZYME IMMUNOASSAY | SERUM [Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration] + Clinical History |
2-8°C (7 days); F (3 MONTHS) | This assay is useful for assessing muscle damage from any cause. Elevated myoglobin levels are seen in cases of acute muscle injury, resuscitation, myopathies, shock & strenuous body activity. Extreme elevation occurs in Rhabdomyolysis. |
| 201 | 1515 | NON-GYNAEC CYTOLOGY & FINE NEEDLE ASPIRATION CYTOLOGY (FNAC) |
CYTOLOGY | UNSTAINED FNAC SMEARS OR BODY FLUIDS OR ASPIRATES + SITE OF COLLECTION+ CLINICAL HISTORY &/OR RADIOLOGICAL FINDGS. | A-SMEARS OR R – FLUIDS /ASPIRATES, IF FLUID SENT WITHIN 24 HRS. FOR MORE THAN 24 HRS, MIX EQUAL PROPORTION OF FLUID WITH 50% ALCOHOL |
Aspiration cytology from a variety of organ sites is useful in the determination of pathologic states particularly neoplasms & inflammatory conditions. Most common sites examined include breast, liver, kidney, lung, prostate, pancreas, retroperitoneum, salivary glands, thyroid & lymph nodes. |
| 202 | 2121 | NT-PRO BNP (N-TERMINAL PRO B TYPE NATRIURETIC PEPTIDE) | ELECTROCHEMILUMINESCENCE | SERUM [Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration] + Clinical History |
2-8°C (6 DAYS); F (3 MONTHS) | This test is used as an aid in the diagnosis of suspected cases of Chronic Heart Failure (CHF). It also detects mild forms of cardiac dysfunction. |
| 203 | LC001 | OPERATION THEATRE MICROBIOLOGICAL SURVEILLANCE (10 SWABS+2 AIR SAMPLES) | AEROBIC+ANAEROBIC CULTURE | AIR SAMPLES + SWABS. | R | To detect and identify the bacteria |
| 204 | LC002 | OPERATION THEATRE MICROBIOLOGICAL SURVEILLANCE (5 SWABS+2 AIR SAMPLES) | AEROBIC+ANAEROBIC CULTURE | AIR SAMPLES + SWABS. | R | To detect and identify the bacteria |
| 205 | 3231U24 | OSMOLALITY, 24 hrs URINE | FREEZING POINT DEPRESSION | URINE 24 HRS WITHOUT PRESERVATIVE & REFRIGERATE DURING COLLECTION) ( PATIENT AGE, GENDER AND CLINICAL HISTORY IS MANDATORY.) | 2-8°C (7 DAYS) | Osmolality is an index of solute concentration. It corresponds to urine specific gravity in non diesese states. This assay assesses the concentrating and diluting ability of kidneys. Preferebly urine and serum osmolalities should be measured simultaneously. |
| 206 | 3231 | OSMOLALITY, SERUM | FREEZING POINT DEPRESSION | SERUM ( PATIENT AGE, GENDER AND CLINICAL HISTORY IS MANDATORY.) | 2-8°C (7 DAYS) | This assay is useful for evaluating acutely ill or comatose patients. It determines osmolality gap in cases of suspected poisonings. An increased gap between measured and calculated osmolality may indicate ingestion of poison, ethylene glycol, methanol and isopropanolol. |
| 207 | 3231U | OSMOLALITY,URINE | FREEZING POINT DEPRESSION | RANDOM URINE WITHOUT PRESERVATIVE( PATIENT AGE, GENDER AND CLINICAL HISTORY IS MANDATORY.) | 2-8°C (7 DAYS) | Osmolality is an index of solute concentration. It corresponds to urine specific gravity in non diesese states. This assay assesses the concentrating and diluting ability of kidneys. Preferebly urine and serum osmolalities should be measured simultaneously. |
| 208 | 3941 | PARATHYROID HORMONE (PTH) INTACT | FLUOROENZYME IMMUNOASSAY / CHEMILUMINESCENCE |
EDTA Plasma for iPTH (Freeze the Plasma immediately after collection) + Clinical History | 2-8°C (2 DAYS); F (> 2 DAYS) & FROZEN EDTA PLASMA | This assay is useful for diagnosis and differential diagnosis of hypercalcemia. It also helps in the diagnosis of Primary / Secondary / Tertiary Hyperparathyroidis m and Hypoparathyroidis m. The assay may be useful in monitoring End stage renal failure patients for possible Renal osteodystrophy. |
| 209 | 5192 | PERICARDIAL FLUID ANALYSIS | SPECTROPHOTOMETRY / MICROSCOPY | FLUID | STERILE CONTAINER | When a healthcare practitioner suspects that you have a condition associated with inflammation of the pericardium and/or fluid accumulation around your heart |
| 210 | 5162 | PERIPHERAL SMEAR EXAM, EDTA WHOLE BLOOD | MICROSCOPY/ 5 PART AUTOANALYSER | EDTA WHOLE BLOOD , SMEARS | EDTA ,SMEARS | To help diagnose disorders of blood cells, parasites etc. |
| 211 | 5193A | PERITONEAL FLUID, ROUTINE | SPECTROPHOTOMETRY / MICROSCOPY | PERITONEAL FLUID | STERILE CONTAINER | When you have abdominal pain and swelling, nausea, and/or fever and your healthcare practitioner suspects you have peritonitis or ascites |
| 212 | 1591UH | PHOSPHORUS, 24HRS URINE | SPECTROPHOTOMETRY | 24HR URINE/RANDOM | URINE CONTAINER | Evaluation of hypo- or hyper-phosphatemic states. Evaluation of patients with nephrolithiasis |
| 213 | 1591H | PHOSPHORUS, SERUM | SPECTROPHOTOMETRY | SERUM | RED /GEL | To evaluate the level of phosphorus in your blood. Evaluation of hypo- or hyper-phosphatemic states. |
| 214 | 5160 | PLATELET COUNT, EDTA WHOLE BLOOD | MICROSCOPY/ 5 PART AUTOANALYSER | EDTA WHOLE BLOOD , SMEARS | SMEARS | To determine the number of platelets in a sample of your blood as part of a health exam; to screen for, diagnose, or monitor conditions that affect the number of platelets, such as a bleeding disorder, a bone marrow disease, or other underlying condition |
| 215 | 5196 | PLEURAL FLUID, ROUTINE | SPECTROPHOTOMETRY / MICROSCOPY | PLEURAL FLUID | STERILE CONTAINER | To help diagnose the cause of accumulation of fluid in the chest cavity (pleural effusion) |
| 216 | 5311UHD | POTASSIUM, RANDOM / 24 HRS URINE | SPECTROPHOTOMETRY | 24HR URINE/RANDOM | URINE CONTAINER | Determining the cause for hyper- or hypokalemia |
| 217 | 5311HD | POTASSIUM, SERUM | SPECTROPHOTOMETRY | SERUM | RED /GEL | POTASSIUM, SERUM Hypokalemia (low K) is common in vomiting, diarrhea, alcoholism, folic acid deficiency and primary aldosteronism. Hyperkalemia may be seen in end-stage renal failure, hemolysis, trauma, Addison””””s disease, metabolic acidosis, acute starvation, dehydration, and with rapid K infusion. |
| 218 | 3226 | PROCALCITONIN | FLUOROENZYME IMMUNOASSAY / CHEMILUMINESCENCE |
SERUM [Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration] + Clinical History |
2-8°C (24 HRS); F (>24 HRS-3 MONTH) | This assay is useful for diagnosis of bacteremia & septicemia in adults and children including neonates. It diagnoses renal involvement in UTI in children, bacterial infection in neutropenic patients & secondary infection post surgery. It helps in the differential diagnosis of bacterial versus viral meningitis and community acquired bacterial versus viral pneumonia. It is also used for monitoring therapeutic response to antibacterial therapy. |
| 219 | 3163 | PROGESTERONE | FLUOROENZYME IMMUNOASSAY / CHEMILUMINESCENCE |
SERUM ( Age+ Gender+ LMP +Clinical History Required) | 2-8°C (48 hrs); F (>48 hrs) | This assay is useful for ascertaining whether ovulation occured in a menstrual cycle. It helps to evaluate placental function in pregnancy and maybe used in the workup of patients with Adrenal / Testicular tumors. |
| 220 | 3206 | PROLACTIN | FLUOROENZYME IMMUNOASSAY / CHEMILUMINESCENCE |
SERUM – Draw sample between 8:00 AM & 10:00 AM. 3 – 4 hrs after patient has awakened.(Clinical History Required) | 2-8°C (48 hrs); F (>48 hrs) | To help investigate unexplained flow of breast milk (galactorrhea), abnormal nipple discharge, absence of menstrual periods, and/or infertility in women; in men, to help diagnose the cause of decreased libido and/or erectile dysfunction; to detect and monitor a pituitary tumor that produces prolactin (prolactinoma) |
| 221 | 3546 | PROSTATE SPECIFIC ANTIGEN (PSA) TOTAL | FLUOROENZYME IMMUNOASSAY / CHEMILUMINESCENCE |
SERUM (AGE+GENDER+ CLINICAL HISTORY REQUIRED) DO NOT SCHEDULE ANY PROSTATIC EXAMINATION / INSTRUMENTATION ATLEAST FOR 3 DAYS BEFORE BLOOD TEST IS PERFORMED. | 2-8°C (24 hrs); F (3 Months) | This assay is used for monitoring patients with a history of Prostate cancer and as an early indicator of recurrence and response to treatment. The test is commonly used for Prostate cancer screening. |
| 222 | 3545 | PROSTATE SPECIFIC ANTIGEN, FREE | FLUOROENZYME IMMUNOASSAY / CHEMILUMINESCENCE |
SERUM (AGE+GENDER+ CLINICAL HISTORY REQUIRED) DO NOT SCHEDULE ANY PROSTATIC EXAMINATION / INSTRUMENTATION ATLEAST FOR 3 DAYS BEFORE BLOOD TEST IS PERFORMED. | 2-8°C (24 hrs); F ( >24 hrs) | PSA exists in serum in complexed and unbound form (free PSA). Higher total PSA levels with lower percentage of free PSA are associated with high risk of Prostate cancer. |
| 223 | 1324U | PROTEIN, 24HRS URINE | SPECTROPHOTOMETRY | 24HR URINE/RANDOM | URINE CONTAINER | To measure the total amount of protein in the urine. To help diagnose certain kidney disorders as well as other diseases. |
| 224 | 1580H | PROTEIN, ALBUMIN,GLOBULIN,A/G RATIO, SERUM | SPECTROPHOTOMETRY | SERUM | RED /GEL | Serum total protein,also known as total protein, is a biochemical test for measuring the total amount of protein in serum..Protein in the plasma is made up of albumin and globulin. Higher than normal levels may be due to: Chronic inflammation or infection, including HIV and hepatitis B or C, Multiple myeloma, Waldenstrom’s disease. Lower than normal levels may be due to: Agammaglobulinemia, Bleeding (hemorrhage),Burns ,Glomerulonephritis, Liver disease, Malabsorption,Malnutrition,Nephrotic syndrome,Protein-losing enteropathy etc. Low blood albumin levels (hypoalbuminemia) can be caused by:Liver disease like cirrhosis of the liver, nephrotic syndrome, protein-losing enteropathy,Burns,,hemodilution, increased vascular permeability or decreased lymphatic clearance,malnutrition and wasting etc. |
| 225 | 3892 | PROTHROMBIN TIME, PLASMA | COAGULOMETER | FROZEN CITRATE PPP AT -20 C | CITRATE TUBE | A prothrombin time (PT) is a test used to help detect and diagnose a bleeding disorder or excessive clotting disorder |
| 226 | 9077 | RAPID TYPHI IgG & IgM (TYPHI CHECK) | RAPID QUALITATIVE SANDIWICH IMMUNOASSAY | SERUM/EDTA PLASMA | EDTA | RAPID TYPHI IgM Typhoid fever is a bacterial infection caused by Salmonella serotypes including S.typhi, S.paratyphi A, S. paratyphi B and Salmonella sendai. The symptoms of the illness include high fever, headache, abdominal pain, constipation and appearance of skin rashes. Accurate diagnosis of typhoid fever at an early stage is not only important for etiological diagnosis but to identify and treat the potential carriers and prevent acute typhoid fever outbreaks. The conventional WIDAL test usually detects antibodies to S.typhi in the patient serum from the second week of onset of the symptoms. Early rising antibodies to Lypopolysaccharides (LPS) O are predominantly IgM in nature. Test Utility: Detection of S.typhi specific IgM antibodies instead of IgG or both IgG and IgM (as measured by Widal test) serve as a rapid marker for recent infection. Limitations: A negative result does not rule out recent of current infection, as the positivity is influenced by the time elapsed from the onset of fever and immunocompetence of the patient. However, if S.typhi infection is still suspected, retesting with second specimen obtained 5-7 days later is recommended. |
| 227 | 9075 | RAPID TYPHI IgM (TYPHI CHECK) | IMMUNOCHROMATOGRAPHY | SERUM/PLASMA EDTA/EDTA WHOLE BLOOD | 2-8°C (24 HRS),> 24 HRS 20 °C | To help diagnose Enteric fever |
| 228 | 5200R | REDUCING SUBSTANCES IN PAEDIATRIC URINE SPECIMENS(UPTO 1 YEAR AGE) | QUALITATIVE CHEMICAL ANALYSIS | RANDOM URINE WITHOUT PRESERVATIVE + CLINICAL HISTORY & AGE IS MANDATORY) | 2-8°C (24 HRS) | Screening test for inborn errors of carbohydrate metabolism |
| 229 | 2365 | REDUCING SUBSTANCES, STOOL | QUALITATIVE CHEMICAL ANALYSIS | STOOL IN LEAK PROOF CONTAINER | R | To help diagnose lactose intolerance (and some rare metabolic abnormalities) |
| 230 | 5170 | RETICULOCYTE COUNT, EDTA WHOLE BLOOD | MICROSCOPY | EDTA WHOLE BLOOD | EDTA | To help evaluate the bone marrow’s ability to produce red blood cells (RBCs); to help distinguish between various causes of anemia; to help monitor bone marrow response and the return of normal marrow function following chemotherapy, bone marrow transplant, or post-treatment follow-up for iron deficiency anemia, vitamin B12 or folate deficiency anemia, or renal failure |
| 231 | 1540D | RHEUMATOID FACTOR QUANTITATIVE, SERUM | SPECTROPHOTOMETRY | 12 -14 HRS FASTING SERUM (LIPEMIC SAMPLE SHOULD BE AVOIDED) + CLINICAL HISTORY + (AGE & GENDER IS MANDATORY) | 2-8°C (7 DAYS); F (>7 -90 DAYS, IF F WITHIN 24 HRS. OF COLLECTION) | Approximately 85% of patients with Rheumatoid arthritis have detectable RA. It may also be seen in other medical conditions like Sjogren’s syndrome and SLE. |
| 232 | 1328 | RHEUMATOID FACTOR, (QUALITATIVE) SERUM | LATEX PARTICLE AGGLUTINATION METHOD | SERUM | RED | To help diagnose Rheumatoid Arthritis |
| 233 | 7662 | ROTA VIRUS ANTIGEN DETECTION FROM STOOL; RAPID CARD TEST | RAPID IMMUNOCHROMATOGRAPHY | STOOL IN LEAK PROOF CONTAINER | A / R | Rotavirus is one of the commonest causes of severe gastroenteritis in infants and young children. It causes a spectrum of responses that vary from subclinical infection to mild diarrhea to severe dehydrating illness. It poses a special threat to Immunosuppresse d patients for Bone marrow transplantation and elederly patients. It is a common cause of nosocomial infections. |
| 234 | 9421M | RUBELLA IgG & IgM ANTIBODIES | Enzyme Linked Immnunosorbent assay | SERUM | 2-8°C (4 DAYS); -20°C (>4 DAYS) | This assay determines Rubella immune status in individuals. A positive result indicates prior exposure to the virus or response to vaccination. Presence of IgG antibody does not exclude the possibility of ongoing infection. IgM antibody to Rubella is detectable 1125 days after the onset of exanthem, 1520 days after vaccination and in 9097% infants with Congenital rubella between 2 weeks and 3 months after birth. |
| 235 | 9416M | RUBELLA IgG ANTIBODIES | Enzyme Linked Immnunosorbent assay | SERUM | 2-8°C (4 DAYS); -20°C (>4 DAYS) | This assay determines Rubella immune status in individuals. A positive result indicates prior exposure to the virus or response to vaccination. Presence of IgG antibody does not exclude the possibility of ongoing infection. In these cases IgM antibody measurement is indicated. |
| 236 | 2475M | RUBELLA IgM ANTIBODIES | Enzyme Linked Immnunosorbent assay | SERUM | 2-8°C (4 DAYS); -20°C (>4 DAYS) | IgM antibody to Rubella is detectable 1125 days after the onset of exanthem, 1520 days after vaccination and in 90 97% infants with Congenital rubella between 2 weeks and 3 months after birth. |
| 237 | 1715 | SAAG FOR BODY FLUID | SPECTROPHOTOMETRY | SERUM | GEL / RED | #N/A |
| 238 | 1265 | SEMEN ANALYSIS, SEMEN | PHYSICAL, CHEMICAL & MICROSCOPY | SEMEN | PLASTIC DISPOSABLE CONTAINER | As part of infertility testing or after a vasectomy to determine if the operation was successful |
| 239 | 6151 | SEMEN FRUCTOSE | SPECTOPHOTOMETRY | SEMEN + CLINICAL HISTORY(PATIENT SHOULD HAVE 2 TO 7 DAYS OF SEXUAL ABSTINENCE AT THE TIME OF SEMEN COLLECTION, TOTAL EJACULATE SHOULD BE COLLECTED) (PATIENT AGE, GENDER AND CLINICAL HISTORY DETAILS.) | F | Fructose is the energy source for sperm motility. A positive fructose is considered normal. Azoospermia and fructose negative results may indicate an absence of seminal vesicles / vas deferens in the area of seminal vesicles / obstruction of seminal vesicles. |
| 240 | 1079H | SERUM BLOOD UREA NITROGEN | SPECTROPHOTOMETRY | SERUM | RED | Causes of Increased levels Pre renal • High protein diet, Increased protein catabolism, GI haemorrhage, Cortisol, Dehydration, CHF Renal • Renal Failure Post Renal • Malignancy, Nephrolithiasis, ProstatismCauses of decreased levels • Liver disease • SIADH. |
| 241 | 1400 | SICKLING TEST | SODIUM METABISULFIDE/ MICROSCOPY | WB-EDTA +CLINICAL HISTORY | A | A qualitative screening test for sickling haemoglobins |
| 242 | 1256 | SKIN TEST-MANTOUX | MANUAL | OTHERS | OTHERS | a test for immunity to tuberculosis using intradermal injection of tuberculin. |
| 243 | 5306HD | SODIUM, SERUM | IMT | SERUM | RED | SODIUM, SERUM Increased in dehydration, cushing””””s syndrome, aldosteronism; Decreased in Addison””””s disease, hypopituitarism,liver disease. |
| 244 | 5306UHD | SODIUM, URINE | IMT | 24HR URINE/RANDOM | URINE CONTAINER | To determine whether your sodium level is within normal limits; as part of an electrolyte panel or metabolic panel to help diagnose and determine the cause of an electrolyte imbalance; to help monitor treatment for illnesses that can cause abnormal sodium levels in the body. |
| 245 | 1324UC | SPOT URINARY PROTEIN (ALBUMIN) CREATININE RATIO | SPECTROPHOTOMETRY | URINE 24 HRS OR RANDOM URINE | PLASTIC DISPOSABLE CONTAINER | To screen for excess protein in the urine, to help evaluate and monitor kidney function, and to detect kidney damage |
| 246 | 1324RU | SPOT URINARY PROTEIN, URINE | SPECTROPHOTOMETRY | URINE 24 HRS WITHOUT PRESERVATIVE & REFRIGERATE DURING COLLECTION) ( PATIENT AGE, GENDER AND CLINICAL HISTORY DETAILS.) | CLEAN BOTTLE OF 2 LITER CAPACITY WITH CAP | #N/A |
| 247 | 3441UACR | SPOT URINE MICROALBUMIN CREATININE RATIO(ACR) | SPECTROPHOTOMETRY | MID STREAM URINE SAMPLE F/B 24 HR URINE COLLECTION | PLASTIC DISPOSABLE CONTAINER & CLEAN BOTTLE OF 2 LITER CAPACITY WITH CAP | MICROALBUMINURIA, URINE Microalbuminuria is defined as an increase in urinary excretion of albumin above the reference interval for healthy nondiabetic subjects but at a concentration that is generally detectable by crude clinical tests such as dipstics designed to measure total protein.the diagnosis of microalbuminuria requires demonstartion of increased albumin secretion in atleasy two out of three urine samples collected in the absence of infection or an acute metabolic crisis. It is now considered a clinically important indicator of detiriorating renal function in diabetic subjects..in .diabetic..patients. Regular screening of urinary albumin secretion is valuable in monitoring both type 1 and type 2 diabetes. Screening should comence 5 years after diagnosis in patients with type 1 diabetes and at diagnosis in patients with type 2 diabetes without proteinuria. Screening is not indicated in patients with established proteinuria. All the patients with diabetes mellitus should be screened on annual basis upto the age of 75 years. It is important to consider causes of increased albumin excretion, specially in cases of type 1 diabetes present for less than 5 years. These can include nondiabetic renal disease, menstural contamination, vaginal discharge, uncontrolled hypertension , urinary tract infection, heart failure, and strenous exercise. |
| 248 | 2367 | STOOL FOR OCCULT BLOOD | MICROSCOPY | STOOL | A | To screen for digestive tract bleeding |
| 249 | 2361 | STOOL: OVA & PARASITE | MICROSCOPY | STOOL | PLASTIC DISPOSABLE CONTAINER | To help diagnose certain conditions affecting the digestive tract. These conditions can include infection (such as from parasites, viruses, or bacteria), poor nutrient absorption and other disorders |
| 250 | 5191 | SYNOVIAL FLUID, ROUTINE | SPECTROPHOTOMETRY / MICROSCOPY | FLUID | STERILE CONTAINER | To help diagnose the cause of joint inflammation, pain, and/or swelling |
| 251 | 9020E | SYPHILIS ANTIBODIES | Chemiluminescent Microparticle Immunoassay (CMIA) | SERUM | 2-8°C (48 HRS); -20°C (>48 HRS) | To help diagnose an infection caused by Treponema Pallidum |
| 252 | 3244 | TESTOSTERONE, TOTAL | FLUOROENZYME IMMUNOASSAY / CHEMILUMINESCENCE |
SERUM (Age + Gender to be mentioned). Sample to be drawn in the morning hrs. | 2-8°C (48 HRS); F ( >48 HRS) | This assay is useful for evaluation of men with signs and symptoms of possible Hypogonadism like loss of libido, erectile dysfunction, gynecomastia & infertility. It is also useful in evaluation of boys with delayed or precocious puberty. The assay can be used to monitor anti androgen therapy as in prostate cancer, precocious puberty & male to female transgender disorders. It helps to evaluate infants with ambiguous genitalia or virilization. The assay can serve as an adjunct in the diagnosis of androgen secreting tumors. |
| 253 | 3250C | THYROID STIMULATING HORMONE (TSH) | CHEMILUMINESCENCE | SERUM ( Age+Gender mandatory) | 2-8°C (48 hrs); F (>48 hrs) | TSH is an early indicator of decreased thyroid reserve. This assay helps to diagnose hypothyroidism and hyperthyroidism, monitors T4 replacement or T4 suppressive therapy and quantifies TSH levels in the subnormal range. |
| 254 | 3226C | THYROXINE T4 | CHEMILUMINESCENCE | SERUM ( Age+Gender mandatory) | 2-8°C (48 hrs); F (>48 hrs) | This assay is a useful test for Hyperthyroidism in patients with low TSH and normal T4 levels. It is also used for the diagnosis of T3 toxicosis. It is not a reliable marker for Hypothyroidism. This test is not recommended for general screening of the population without a clinical suspicion of hyperthyroidism. |
| 255 | 9362 | TISSUE TRANSGLUTAMINASE IgA, TTG | Enzyme Linked Immnunosorbent assay | SERUM | 2-8°C (48 hrs.); -20°C (>48 hrs.) | This assay is useful in evaluating patients with Celiac disease including those with compatible symptoms, atypical symptoms and individuals at increased risk like positivity for HLA DQ2 / DQ8. It is also used as a screening test for Dermatitis herpetiformis. The test monitors adherence to gluten free diet. |
| 256 | 3533HD | TOTAL IRON BINDING CAPACITY (TIBC), SERUM | SPECTROPHOTOMETRY | SERUM | RED | TOTAL IRON BINDING CAPACITY, SERUM Total iron binding capacity (TIBC) measures the blood’s capacity to bind iron with transferrin and thus is an indirect way of assessing transferrin level. Taken together with serum iron and percent transferrin saturation this test is performed when they is a concern about anemia, iron deficiency or iron deficiency anemia. However, because the liver produces transferrin, alterations in liver function (such as cirrhosis, hepatitis, or liver failure) must be considered when performing this test. Increased in: – iron deficiency – acute and chronic blood loss – acute liver damage – progesterone birth control pills Decreased in: – hemochromatosis – cirrhosis of the liver – thalassemia – anemias of infection and chronic diseases – nephrosis – hyperthyroidism The percent Transferrin saturation = Serum Iron/TIBC x 100 Unsaturated Binding Capacity (UIBC)=TIBC – Serum Iron. Limitations: Estrogens and oral contraceptives increase TIBC and Asparaginase, chloramphenicol, corticotropin, cortisone and testosterone decrease the TIBC level. Reference: 1.Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, edited by Carl A Burtis, Edward R.Ashwood, David E Bruns, 4th Edition, Elsevier publication, 2006, 563, 1314-1315. 2. Wallach’s Interpretation of Diagnostic tests, 9th Edition, Ed Mary A Williamson and L Michael Snyder. Pub Lippincott Williams and Wilkins, 2011, 234-235. |
| 257 | 1324F | TOTAL PROTEIN, FLUID | SPECTROPHOTOMETRY | SERUM | RED | Detecting disruptions of the blood-brain barrier or intrathecal synthesis of immunoglobulins. |
| 258 | 1324H | TOTAL PROTEIN, SERUM | SPECTROPHOTOMETRY | SERUM | RED | To measure the total amount of protein in the serum. To determine the nutritional status or to help diagnose certain liver and kidney disorders as well as other diseases. |
| 259 | 2261M | TOXOPLASMA IgG & IgM ANTIBODIES | Enzyme Linked Immnunosorbent assay | SERUM | 2-8°C (4 DAYS); -20°C (>4 DAYS) | Toxoplasmosis is caused by the parasite Toxoplasma gondii. About 23% of the population are healthy carriers. Trans mission from a pregnant woman to the fetus can cause serious disease. IgG antibodies are useful for indicating past or recent infection with Toxoplasma gondii. IgM antibodies aid in the diagnosis of Congenital / Acute acquired Toxoplasmosis. |
| 260 | 9426M | TOXOPLASMA IgG ANTIBODIES | Enzyme Linked Immnunosorbent assay | SERUM | 2-8°C (4 DAYS); -20°C (>4 DAYS) | Toxoplasmosis is caused by the parasite Toxoplasma gondii. About23% of the population are healthy carriers. Transmission from a pregnant woman to the fetus can cause serious disease. This assay is useful for indicating past or recent infection with Toxoplasma gondii. |
| 261 | 7661M | TOXOPLASMA IgM ANTIBODIES | Enzyme Linked Immnunosorbent assay | SERUM | 2-8°C (4 DAYS); -20°C (>4 DAYS) | Toxoplasmosis is caused by the parasite Toxoplasma gondii. About 23% of the population are healthy carriers. Transmission from a pregnant woman to the fetus can cause serious disease. This assay aids in the diagnosis of Congenital / Acute acquired Toxoplasmosis. |
| 262 | 3346HD | TRIGLYCERIDES, SERUM | SPECTROPHOTOMETRY | SERUM | RED | Evaluation of risk factors in individuals with elevated cholesterol values |
| 263 | 3224C | TRIIODOTHYRONINE TOTAL T3 | CHEMILUMINESCENCE | SERUM ( Age+Gender mandatory) | 2-8°C (48 hrs); F (>48 hrs) | This assay is a useful test for Hyperthyroidism in patients with low TSH and normal T4 levels. It is also used for the diagnosis of T3 toxicosis. It is not a reliable marker for Hypothyroidism. This test is not recommended for general screening of the population without a clinical suspicion of hyperthyroidism. |
| 264 | 3395A | TROPONIN T | RAPID | SERUM [Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration] + Clinical History |
2-8°C (24 HRS); F (3 MONTHS) | Troponin T is a marker of Acute Myocardial Infarction rising 24 hours after the onset of Myocardial necrosis and can remain elevated up to 14 days. High levels are also seen in Unstable angina. It may also be used in monitoring patients with nonischemic causes of cardiac injury. |
| 265 | 1079UH | UREA NITROGEN, 24HRS URINE | SPECTROPHOTOMETRY | 24HR URINE/RANDOM | URINE CONTAINER | If your kidney function needs to be evaluated To help determine the effectiveness of dialysis treatment if you’re receiving hemodialysis or peritoneal dialysis |
| 266 | 1310UH | URIC ACID, 24HRS URINE | SPECTROPHOTOMETRY | 24HR URINE/RANDOM | URINE CONTAINER | To detect and to monitor high levels of uric acid in the urine in order to diagnose the cause of kidney stones. |
| 267 | 1310H | URIC ACID, SERUM | SPECTROPHOTOMETRY | SERUM | RED | To detect high levels of uric acid in the blood, which could be a sign of the condition gout, or to monitor uric acid levels when undergoing chemotherapy or radiation treatment; |
| 268 | 5200U | URINALYSIS | DIPSTICK/ MICROSCOPY | URINE | PLASTIC DISPOSABLE CONTAINER | To screen for, help diagnose and/or monitor several diseases and conditions, such as kidney disorders or urinary tract infections (UTIs) |
| 269 | 4104 | URINE FOR KETONE BODIES | CHEMICAL ANALYSIS | FIRST VOIDED MORNING OR RANDOM | S. CONTAINER | #N/A |
| 270 | 3189 | URINE PREGNANCY TEST | RAPID CARD METHOD | SPOT URINE | A | To screen for a pregnancy |
| 271 | 1717 | VAGINAL SWAB FOR C&S | MANUAL & VITEC | RESPECTIVE SITE | STERILE CONTAINER | #N/A |
| 272 | 1717M | VAGINAL SWAB FOR C&S Manual | MANNUAL METHOD | RESPECTIVE SITE | STERILE CONTAINER | #N/A |
| 273 | 3020 | VITAMIN B12 | CHEMILUMINESCENCE | SERUM FASTING | 2-8°C (48 HRS); F (> 48 HRS) | Vitamin B12 is necessary for hematopoiesis and normal neuronal function. B12 deficiency may be due to lack of intrinsic factor secretion by gastric mucosa (gastrectomy, gastric atrophy) or intestinal malabsorption (ileal resection, small intestinal diseases) leading to Macrocytic anemia. This assay is useful for investigating Macrocytic anemia and as a workup of deficiencies seen in Megaloblastic anemia. |
| 274 | 8823 | VITAMIN D (25-HYDROXY VITAMIN D) | CHEMILUMINESCENCE | SERUM: Fasting not mandatory SERUM [Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration] |
2-8°C (48 hrs); F (>48 hrs) | 25Hydroxy vitamin D represents the main body reservoir and transport form. Mild to moderate deficiency is associated with Osteoporosis / Secondary Hyperparathyroidis m while severe deficiency causes Rickets in children and Osteomalacia in adults. Prevalence of Vitamin D deficiency is approximately >50% specially in the elderly. This assay is useful for diagnosis of vitamin D deficiency and Hypervitaminosis D. It is also used for differential diagnosis of causes of Rickets & Osteomalacia and for monitoring Vitamin D replacement therapy. |
| 275 | 5122 | WHITE CELL COUNT AND DIFFERENTIAL, EDTA WB | 5 PART AUTOANALYSER | EDTA WHOLE BLOOD | EDTA | To screen for or diagnose a variety of conditions that can affect the number of white blood cells (WBCs), such as an infection, inflammation or a disease that affects WBCs; to monitor treatment of a disorder or to monitor therapy that is known to affect WBCs |
| 276 | 9076 | WIDAL AGGLUTINATION | Agglutination method | SERUM | A | The Widal test is one method that may be used to help make a presumptive diagnosis of enteric fever |
| 277 | 4131X | DRUGS OF ABUSE: 9 DRUGS (Amphetamine, Barbiturates, Benzodiazepines, Cocaine, Cannabinoids, Opiates, Phencyclidine, Methamphetamine, Methodone) |
REVERSE IMMUNOCHROMATOGRAPHIC | URINE + CLINICAL HISTORY | A (8HRS); 2- 8° C (3 DAYS);F (>3 DAYS) | Intended use of this assay is to assist in Drug abuse treatment programs, Pain management clinics. Organ transplantation programs & Psychiatric programs. |
| 278 | 1949X | FACTOR X ACTIVITY | CLOT BASED | FASTING, CITRATED PLATELET POOR PLASMA* – AT MINUS 20° C(DOUBLE CENTRIFUGED PLASMA)* + CLINICAL HISTORY | F (TO BE F IMMEDIATELY AT -20°C & TRANSPORTED IN DRY ICE) | |
| 279 | 2366 | VDRL (VENERAL DISEASE RESEARCH LABORATORY) | Flocculation method | SERUM/CSF | A | To screen for or diagnose an infection with the bacterium Treponema pallidum, which causes syphilis, a sexually transmitted disease (STD) |
| 280 | A/G | ALBUMIN / GLOBULIN RATIO | ALBUMIN+GLOBULIN+A/G RATIO, SERUM Serum total protein,also known as total protein, is a biochemical test for measuring the total amount of protein in serum..Protein in the plasma is made up of albumin and globuli. Higher-than-normal levels may be due to: Chronic inflammation or infection, including HIV and hepatitis B or C, Multiple myeloma, Waldenstrom””s disease Lower-than-normal levels may be due to: Agammaglobulinemia, Bleeding (hemorrhage),Burns ,Glomerulonephritis, Liver disease, Malabsorption,Malnutrition,Nephrotic syndrome,Protein-losing enteropathy etc.Human serum albumin is the most abundant protein in human blood plasma. It is produced in the liver. Albumin constitutes about half of the blood serum protein. Low blood albumin levels (hypoalbuminemia) can be caused by:Liver disease like cirrhosis of the liver, nephrotic syndrome, protein-losing enteropathy,Burns,,hemodilution, increased vascular permeability or decreased lymphatic clearance,malnutrition and wasting etc. | |||
| 281 | 5110A11 | BLOOD COUNTS | #N/A | |||
| 282 | B/C | BUN/CREAT RATIO | #N/A | |||
| 283 | C/D | CHOLESTEROL TOTAL/HDL RATIO | #N/A | |||
| 284 | GLOB | GLOBULIN | #N/A | |||
| 285 | 5101A | HEMOGLOBIN | Hemoglobin estimation by cyanmethaemoglobin technique is the gold standard and is used to diagnose anemia or polycythemia. | |||
| 286 | L/H | LDL/HDL RATIO | #N/A | |||
| 287 | 5110D | MORPHOLOGY | #N/A | |||
| 288 | 5110A12 | RBC AND PLATELET INDICES | #N/A | |||
| 289 | 1528HD | SATURATION | #N/A | |||
| 290 | T/H | TESTOSTERONE,FREE % | #N/A | |||
| 291 | VL | VLDL | #N/A | |||
| 292 | 5110C1 | WHITE CELL COUNT AND DIFFERENTIAL, EDTA WB | #N/A | |||
| 293 | 5170A | RETICULOCYTE COUNT, BLOOD | Reticulocytes are juvenile red cells and contain a reticular (mesh-like) network of RNA. The number of reticulocytes is a good indicator of erythropoetic activity, and can be used to monitor the response to treatment of anemia. Decrease in reticulocytes can be attributed to suppression of erythropoiesis due to chemotherapy, aplastic anemia and other hypoproliferative anemias. An increased number of reticulocytes (reticulocytosis) indicates accelerated erythropoiesis; either as compensation for excessive red cell loss (e.g. hemolysis or bleeding) or, when a marrow starved of iron, vitamin B12 or folate receives the appropriate nutrient. | |||
| 294 | 5101B | TOTAL LEUKOCYTE COUNT | #N/A | |||
| 295 | 5101C | WHITE CELL COUNT AND DIFFERENTIAL, EDTA WB | #N/A |